☰

George Klein - Publications

Affiliations: 
Tumor Biology Karolinska Institute, Stockholm, Sweden 
Tree Info Similar researchers PubMed Report error

500 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Wu L, Ehlin-Henriksson B, Zhou X, Zhu H, Ernberg I, Kis LL, Klein G. EBV provides survival factors to EBV+ DLBCL lines and modulates cytokine induced specific chemotaxis in EBV+ DLBCL. Immunology. PMID 28699226 DOI: 10.1111/Imm.12792  0.371
2017 Alkasalias T, Alexeyenko A, Hennig K, Danielsson F, Lebbink RJ, Fielden M, Turunen SP, Lehti K, Kashuba V, Madapura HS, Bozoky B, Lundberg E, Balland M, Guvén H, Klein G, et al. RhoA knockout fibroblasts lose tumor-inhibitory capacity in vitro and promote tumor growth in vivo. Proceedings of the National Academy of Sciences of the United States of America. PMID 28174275 DOI: 10.1073/Pnas.1621161114  0.32
2017 Suhovskih AV, Kashuba VI, Klein G, Grigorieva EV. Prostate cancer cells specifically reorganize epithelial cell-fibroblast communication through proteoglycan and junction pathways. Cell Adhesion & Migration. 11: 39-53. PMID 27111714 DOI: 10.1080/19336918.2016.1182292  0.344
2015 Klein G. Tumor Associations of EBV-Historical Perspectives. Current Topics in Microbiology and Immunology. 390: 17-22. PMID 26424641 DOI: 10.1007/978-3-319-22822-8_2  0.368
2015 Mushtaq M, Darekar S, Klein G, Kashuba E. Different Mechanisms of Regulation of the Warburg Effect in Lymphoblastoid and Burkitt Lymphoma Cells. Plos One. 10: e0136142. PMID 26312753 DOI: 10.1371/Journal.Pone.0136142  0.397
2014 Alkasalias T, Flaberg E, Kashuba V, Alexeyenko A, Pavlova T, Savchenko A, Szekely L, Klein G, Guven H. Inhibition of tumor cell proliferation and motility by fibroblasts is both contact and soluble factor dependent. Proceedings of the National Academy of Sciences of the United States of America. 111: 17188-93. PMID 25404301 DOI: 10.1073/Pnas.1419554111  0.344
2014 Rasul E, Salamon D, Nagy N, Leveau B, Banati F, Szenthe K, Koroknai A, Minarovits J, Klein G, Klein E. The MEC1 and MEC2 lines represent two CLL subclones in different stages of progression towards prolymphocytic leukemia. Plos One. 9: e106008. PMID 25162594 DOI: 10.1371/Journal.Pone.0106008  0.383
2014 Heuts F, Rottenberg ME, Salamon D, Rasul E, Adori M, Klein G, Klein E, Nagy N. T cells modulate Epstein-Barr virus latency phenotypes during infection of humanized mice. Journal of Virology. 88: 3235-45. PMID 24390326 DOI: 10.1128/Jvi.02885-13  0.391
2013 Wu L, Ehlin-Henriksson B, Zhu H, Ernberg I, Klein G. EBV counteracts IL-21-induced apoptosis in an EBV-positive diffuse large B-cell lymphoma cell line. International Journal of Cancer. 133: 766-70. PMID 23364893 DOI: 10.1002/Ijc.28067  0.327
2013 Bozóky B, Savchenko A, Csermely P, Korcsmáros T, Dúl Z, Pontén F, Székely L, Klein G. Novel signatures of cancer-associated fibroblasts. International Journal of Cancer. 133: 286-93. PMID 23319410 DOI: 10.1002/Ijc.28035  0.326
2013 Darekar S, Georgiou K, Yurchenko M, Yenamandra SP, Chachami G, Simos G, Klein G, Kashuba E. Schematic view on the role of HIF1A in EBV-infected B-cell. Plos One. DOI: 10.1371/Journal.Pone.0042072.G007  0.331
2012 Madapura HS, Salamon D, Wiman KG, Lain S, Klein G, Klein E, Nagy N. p53 contributes to T cell homeostasis through the induction of pro-apoptotic SAP. Cell Cycle (Georgetown, Tex.). 11: 4563-9. PMID 23165210 DOI: 10.4161/Cc.22810  0.306
2012 Rasul AE, Nagy N, Sohlberg E, Ádori M, Claesson HE, Klein G, Klein E. Simultaneous detection of the two main proliferation driving EBV encoded proteins, EBNA-2 and LMP-1 in single B cells. Journal of Immunological Methods. 385: 60-70. PMID 22921685 DOI: 10.1016/J.Jim.2012.08.008  0.413
2012 Darekar S, Georgiou K, Yurchenko M, Yenamandra SP, Chachami G, Simos G, Klein G, Kashuba E. Epstein-barr virus immortalization of human B-cells leads to stabilization of hypoxia-induced factor 1 alpha, congruent with the Warburg effect Plos One. 7. PMID 22848707 DOI: 10.1371/Journal.Pone.0042072  0.389
2012 Dmitriev AA, Kashuba VI, Haraldson K, Senchenko VN, Pavlova TV, Kudryavtseva AV, Anedchenko EA, Krasnov GS, Pronina IV, Loginov VI, Kondratieva TT, Kazubskaya TP, Braga EA, Yenamandra SP, Ignatjev I, ... ... Klein G, et al. Genetic and epigenetic analysis of non-small cell lung cancer with NotI-microarrays. Epigenetics : Official Journal of the Dna Methylation Society. 7: 502-13. PMID 22491060 DOI: 10.4161/Epi.19801  0.315
2012 Flaberg E, Guven H, Savchenko A, Pavlova T, Kashuba V, Szekely L, Klein G. The architecture of fibroblast monolayers of different origin differentially influences tumor cell growth International Journal of Cancer. 131: 2274-2283. PMID 22396138 DOI: 10.1002/Ijc.27521  0.364
2012 Salamon D, Adori M, Ujvari D, Wu L, Kis LL, Madapura HS, Nagy N, Klein G, Klein E. Latency type-dependent modulation of Epstein-Barr virus-encoded latent membrane protein 1 expression by type I interferons in B cells. Journal of Virology. 86: 4701-7. PMID 22345482 DOI: 10.1128/Jvi.06829-11  0.384
2012 Nagy N, Adori M, Rasul A, Heuts F, Salamon D, Ujvári D, Madapura HS, Leveau B, Klein G, Klein E. Soluble factors produced by activated CD4+ T cells modulate EBV latency. Proceedings of the National Academy of Sciences of the United States of America. 109: 1512-7. PMID 22307606 DOI: 10.1073/Pnas.1120587109  0.395
2012 Yenamandra SP, Darekar SD, Kashuba V, Matskova L, Klein G, Kashuba E. Stem cell gene expression in MRPS18-2-immortalized rat embryonic fibroblasts Cell Death and Disease. 3. PMID 22258410 DOI: 10.1038/Cddis.2011.138  0.363
2012 Salamon D, Adori M, He M, Bönelt P, Severinson E, Kis LL, Wu L, Ujvari D, Leveau B, Nagy N, Klein G, Klein E. Type I interferons directly down-regulate BCL-6 in primary and transformed germinal center B cells: Differential regulation in B cell lines derived from endemic or sporadic Burkitt's lymphoma Cytokine. 57: 360-371. PMID 22204827 DOI: 10.1016/J.Cyto.2011.12.001  0.36
2011 Kis LL, Gerasimčik N, Salamon D, Persson EK, Nagy N, Klein G, Severinson E, Klein E. STAT6 signaling pathway activated by the cytokines IL-4 and IL-13 induces expression of the Epstein-Barr virus-encoded protein LMP-1 in absence of EBNA-2: Implications for the type II EBV latent gene expression in Hodgkin lymphoma Blood. 117: 165-174. PMID 20876453 DOI: 10.1182/Blood-2010-01-265272  0.359
2011 Flaberg E, Markasz L, Petranyi G, Stuber G, Dicso F, Alchihabi N, Oláh È, Csízy I, Józsa T, Andrén O, Johansson JE, Andersson SO, Klein G, Szekely L. High-throughput live-cell imaging reveals differential inhibition of tumor cell proliferation by human fibroblasts. International Journal of Cancer. Journal International Du Cancer. 128: 2793-802. PMID 20715102 DOI: 10.1002/Ijc.25612  0.405
2010 Yenamandra SP, Hellman U, Kempkes B, Darekar SD, Petermann S, Sculley T, Klein G, Kashuba E. Epstein-Barr virus encoded EBNA-3 binds to vitamin D receptor and blocks activation of its target genes Cellular and Molecular Life Sciences. 67: 4249-4256. PMID 20593215 DOI: 10.1007/S00018-010-0441-4  0.368
2010 Klein G, Klein E, Kashuba E. Interaction of Epstein-Barr virus (EBV) with human B-lymphocytes Biochemical and Biophysical Research Communications. 396: 67-73. PMID 20494113 DOI: 10.1016/J.Bbrc.2010.02.146  0.453
2010 Kis LL, Salamon D, Persson EK, Nagy N, Scheeren FA, Spits H, Klein G, Klein E. IL-21 imposes a type II EBV gene expression on type III and type I B cells by the repression of C- and activation of LMP-1-promoter Proceedings of the National Academy of Sciences of the United States of America. 107: 872-877. PMID 20080768 DOI: 10.1073/Pnas.0912920107  0.371
2009 Kashuba E, Yenamandra SP, Darekar SD, Yurchenko M, Kashuba V, Klein G, Szekely L. MRPS18-2 protein immortalizes primary rat embryonic fibroblasts and endows them with stem cell-like properties Proceedings of the National Academy of Sciences of the United States of America. 106: 19866-19871. PMID 19903879 DOI: 10.1073/Pnas.0911545106  0.366
2009 Nagy N, Klein G, Klein E. To the genesis of Burkitt lymphoma: Regulation of apoptosis by EBNA-1 and SAP may determine the fate of Ig-myc translocation carrying B lymphocytes Seminars in Cancer Biology. 19: 407-410. PMID 19874894 DOI: 10.1016/J.Semcancer.2009.10.001  0.414
2009 Nagy N, Matskova L, Hellman U, Klein G, Klein E. The apoptosis modulating role of SAP (SLAM associated protein) contributes to the symptomatology of the X linked lymphoproliferative disease Cell Cycle. 8: 3086-3090. PMID 19738428 DOI: 10.4161/Cc.8.19.9636  0.319
2009 Klein G. Burkitt lymphoma-A stalking horse for cancer research? Seminars in Cancer Biology. 19: 347-350. PMID 19607918 DOI: 10.1016/J.Semcancer.2009.07.001  0.367
2009 Ehlin-Henriksson B, Liang W, Cagigi A, Mowafi F, Klein G, Nilsson A. Changes in chemokines and chemokine receptor expression on tonsillar B cells upon Epstein-Barr virus infection Immunology. 127: 549-557. PMID 19604305 DOI: 10.1111/J.1365-2567.2008.03029.X  0.353
2009 Nagy N, Matskova L, Kis LL, Hellman U, Klein G, Klein E. The proapoptotic function of SAP provides a clue to the clinical picture of X-linked lymphoproliferative disease Proceedings of the National Academy of Sciences of the United States of America. 106: 11966-11971. PMID 19570996 DOI: 10.1073/Pnas.0905691106  0.404
2009 Stuber G, Flaberg E, Petranyi G, Ötvös R, Rökaeus N, Kashuba E, Wiman KG, Klein G, Szekely L. PRIMA-1MET induces nucleolar translocation of Epstein-Barr virus-encoded EBNA-5 protein Molecular Cancer. 8. PMID 19323829 DOI: 10.1186/1476-4598-8-23  0.385
2009 Klein G. Reply to bredberg: The voice of the whale Proceedings of the National Academy of Sciences of the United States of America. 106: E52. DOI: 10.1073/Pnas.0903365106  0.316
2008 Wang F, Grigorieva EV, Li J, Senchenko VN, Pavlova TV, Anedchenko EA, Kudryavtseva AV, Tsimanis A, Angeloni D, Lerman MI, Kashuba VI, Klein G, Zabarovsky ER. HYAL1 and HYAL2 inhibit tumour growth in vivo but not in vitro. Plos One. 3: e3031. PMID 18725949 DOI: 10.1371/Journal.Pone.0003031  0.341
2008 Kashuba E, Yurchenko M, Yenamandra SP, Snopok B, Isaguliants M, Szekely L, Klein G. EBV-encoded EBNA-6 binds and targets MRS18-2 to the nucleus, resulting in the disruption of pRb-E2F1 complexes Proceedings of the National Academy of Sciences of the United States of America. 105: 5489-5494. PMID 18391203 DOI: 10.1073/Pnas.0801053105  0.348
2008 Darai-Ramqvist E, Sandlund A, Müller S, Klein G, Imreh S, Kost-Alimova M. Segmental duplications and evolutionary plasticity at tumor chromosome break-prone regions Genome Research. 18: 370-379. PMID 18230801 DOI: 10.1101/Gr.7010208  0.336
2008 Liu A, Claesson HE, Mahshid Y, Klein G, Klein E. Leukotriene B4 activates T cells that inhibit B-cell proliferation in EBV-infected cord blood derived mononuclear cell cultures Blood. 111: 2693-2703. PMID 18094330 DOI: 10.1182/Blood-2007-08-102319  0.378
2007 Zhou X, Popescu NC, Klein G, Imreh S. The interferon-α responsive gene TMEM7 suppresses cell proliferation and is downregulated in human hepatocellular carcinoma Cancer Genetics and Cytogenetics. 177: 6-15. PMID 17693185 DOI: 10.1016/J.Cancergencyto.2007.04.007  0.334
2007 Klein G, Imreh S, Zabarovsky ER. Why Do We Not All Die of Cancer at an Early Age? Advances in Cancer Research. 98: 1-16. PMID 17433906 DOI: 10.1016/S0065-230X(06)98001-4  0.388
2007 Stuber G, Mattsson K, Flaberg E, Kati E, Markasz L, Sheldon JA, Klein G, Schulz TF, Szekely L. HHV-8 encoded LANA-1 alters the higher organization of the cell nucleus Molecular Cancer. 6. PMID 17433107 DOI: 10.1186/1476-4598-6-28  0.397
2007 Klein E, Kis LL, Klein G. Epstein-Barr virus infection in humans: From harmless to life endangering virus-lymphocyte interactions Oncogene. 26: 1297-1305. PMID 17322915 DOI: 10.1038/Sj.Onc.1210240  0.307
2007 Kost-Alimova M, Darai-Ramqvist E, Yau WL, Sandlund A, Fedorova L, Yang Y, Kholodnyuk I, Cheng Y, Lung ML, Stanbridge E, Klein G, Imreh S. Mandatory chromosomal segment balance in aneuploid tumor cells Bmc Cancer. 7. PMID 17257397 DOI: 10.1186/1471-2407-7-21  0.36
2007 Haltrich I, Kost-Alimova M, Kovács G, Dobos M, Klein G, Fekete G, Imreh S. Multipoint interphase FISH in childhood T-acute lymphoblastic leukemia detects subpopulations that carry different chromosome 3 aberrations Cancer Genetics and Cytogenetics. 172: 54-60. PMID 17175380 DOI: 10.1016/J.Cancergencyto.2006.08.004  0.345
2007 Liu A, Mahshid Y, Claesson H, Klein G, Klein E. 88 Leukotriene B4 Contributes to T Cell Mediated Inhibition of B Cell Growth in the EBV Infected Cord Blood Mononuclear Cell Cultures Cytokine. 39: 24-24. DOI: 10.1016/J.Cyto.2007.07.093  0.352
2006 Darai-Ramqvist E, Diaz de Ståhl T, Sandlund A, Mantripragada K, Klein G, Dumanski J, Imreh S, Kost-Alimova M. Array-CGH and multipoint FISH to decode complex chromosomal rearrangements Bmc Genomics. 7. PMID 17196103 DOI: 10.1186/1471-2164-7-330  0.327
2006 Takahara M, Kis LL, Nagy N, Liu A, Harabuchi Y, Klein G, Klein E. Concomitant increase of LMP1 and CD25 (IL-2-receptor α) expression induced by IL-10 in the EBV-positive NK lines SNK6 and KAI3 International Journal of Cancer. 119: 2775-2783. PMID 17013900 DOI: 10.1002/Ijc.22139  0.315
2006 Ehlin-Henriksson B, Mowafi F, Klein G, Nilsson A. Epstein-Barr virus infection negatively impacts the CXCR4-dependent migration of tonsillar B cells Immunology. 117: 379-385. PMID 16476057 DOI: 10.1111/J.1365-2567.2005.02311.X  0.392
2006 Kholodnyuk ID, Kozireva S, Kost-Alimova M, Kashuba V, Klein G, Imreh S. Down regulation of 3p genes, LTF, SLC38A3 and DRR1, upon growth of human chromosome 3-mouse fibrosarcoma hybrids in severe combined immunodeficiency mice International Journal of Cancer. 119: 99-107. PMID 16432833 DOI: 10.1002/Ijc.21794  0.31
2006 Kis LL, Takahara M, Nagy N, Klein G, Klein E. Cytokine mediated induction of the major Epstein-Barr virus (EBV)-encoded transforming protein, LMP-1 Immunology Letters. 104: 83-88. PMID 16386314 DOI: 10.1016/J.Imlet.2005.11.003  0.414
2006 Kis LL, Takahara M, Nagy N, Klein G, Klein E. IL-10 can induce the expression of EBV-encoded latent membrane protein-1 (LMP-1) in the absence of EBNA-2 in B lymphocytes and in Burkitt lymphoma-and NK lymphoma-derived cell lines Blood. 107: 2928-2935. PMID 16332968 DOI: 10.1182/Blood-2005-06-2569  0.379
2006 Kashuba EV, Gradin K, Isaguliants M, Szekely L, Poellinger L, Klein G, Kazlauskas A. Regulation of transactivation function of the aryl hydrocarbon receptor by the Epstein-Barr virus-encoded EBNA-3 protein. The Journal of Biological Chemistry. 281: 1215-23. PMID 16257957 DOI: 10.1074/Jbc.M509036200  0.371
2005 Klein G, Klein E. Surveillance against tumors - Is it mainly immunological? Immunology Letters. 100: 29-33. PMID 16129497 DOI: 10.1016/J.Imlet.2005.06.024  0.363
2005 Darai E, Kost-Alimova M, Kiss H, Kansoul H, Klein G, Imreh S. Evolutionarily plastic regions at human 3p21.3 coincide with tumor breakpoints identified by the "elimination test" Genomics. 86: 1-12. PMID 15913951 DOI: 10.1016/J.Ygeno.2005.04.003  0.32
2005 Bandobashi K, Liu A, Nagy N, Kis LL, Nishikawa J, Björkholm M, Klein G, Klein E. EBV infection induces expression of the transcription factors ATF-2/c-Jun in B lymphocytes but not in B-CLL cells Virus Genes. 30: 323-330. PMID 15830149 DOI: 10.1007/S11262-004-6774-Z  0.406
2005 Benedek K, Chudoba I, Klein G, Wiener F, Mai S. Rearrangements of the telomeric region of mouse chromosome 11 in Pre-B ABL/MYC cells revealed by mBANDing, spectral karyotyping, and fluorescence in-situ hybridization with a subtelomeric probe Chromosome Research. 12: 777-785. PMID 15702416 DOI: 10.1007/S10577-005-5264-Z  0.337
2005 Silva S, Wiener F, Klein G, Janz S. Location of Myc, Igh, and Igk on Robertsonian fusion chromosomes is inconsequential for Myc translocations and plasmacytoma development in mice, but Rb(6.15)-carrying tumors prefer Igk-Myc inversions over translocations Genes Chromosomes and Cancer. 42: 416-426. PMID 15645495 DOI: 10.1002/Gcc.20149  0.31
2005 Kashuba E, Yurchenko M, Szirak K, Stahl J, Klein G, Szekely L. Epstein-Barr virus-encoded EBNA-5 binds to Epstein-Barr virus-induced Fte1/S3a protein Experimental Cell Research. 303: 47-55. PMID 15572026 DOI: 10.1016/J.Yexcr.2004.08.025  0.406
2005 Kis LL, Nishikawa J, Takahara M, Nagy N, Matskova L, Takada K, Elmberger PG, Ohlsson A, Klein G, Klein E. In vitro EBV-infected subline of KMH2, derived from Hodgkin lymphoma, expresses only EBNA-1, while CD40 ligand and IL-4 induce LMP-1 but not EBNA-2 International Journal of Cancer. 113: 937-945. PMID 15514968 DOI: 10.1002/Ijc.20654  0.415
2005 Liu A, Arbiser JL, Holmgren A, Klein G, Klein E. PSK and Trx80 inhibit B-cell growth in EBV-infected cord blood mononuclear cells through T cells activated, by the monocyte products IL-15 and IL-12 Blood. 105: 1606-1613. DOI: 10.1182/Blood-2004-06-2406  0.371
2004 Louis S, Benedek K, Mowat M, Klein G, Mai S. Elongated mouse chromosomes suitable for enhanced molecular cytogenetics. Cytotechnology. 44: 143-9. PMID 19003236 DOI: 10.1007/S10616-004-2978-2  0.309
2004 Sharp TV, Munoz F, Bourboulia D, Presneau N, Darai E, Wang HW, Cannon M, Butcher DN, Nicholson AG, Klein G, Imreh S, Boshoff C. LIM domains-containing protein 1 (LIMD1), a tumor suppressor encoded at chromosome 3p21.3, binds pRB and represses E2F-driven transcription. Proceedings of the National Academy of Sciences of the United States of America. 101: 16531-6. PMID 15542589 DOI: 10.1073/Pnas.0407123101  0.312
2004 Nagy N, Takahara M, Nishikawa J, Bourdon JC, Kis LL, Klein G, Klein E. Wild-type p53 activates SAP expression in lymphoid cells Oncogene. 23: 8563-8570. PMID 15378026 DOI: 10.1038/Sj.Onc.1207908  0.388
2004 Li J, Wang F, Haraldson K, Protopopov A, Duh FM, Geil L, Kuzmin I, Minna JD, Stanbridge E, Braga E, Kashuba VI, Klein G, Lerman MI, Zabarovsky ER. Functional characterization of the candidate tumor suppressor gene NPRL2/G21 located in 3p21.3C. Cancer Research. 64: 6438-43. PMID 15374952 DOI: 10.1158/0008-5472.Can-03-3869  0.346
2004 Carbone M, Klein G, Gruber J, Wong M. Modern criteria to establish human cancer etiology. Cancer Research. 64: 5518-24. PMID 15289363 DOI: 10.1158/0008-5472.Can-04-0255  0.303
2004 Li J, Wang F, Protopopov A, Malyukova A, Kashuba V, Minna JD, Lerman MI, Klein G, Zabarovsky E. Inactivation of RASSF1C during in vivo tumor growth identifies it as a tumor suppressor gene. Oncogene. 23: 5941-9. PMID 15208682 DOI: 10.1038/Sj.Onc.1207789  0.392
2004 Senchenko VN, Liu J, Loginov W, Bazov I, Angeloni D, Seryogin Y, Ermilova V, Kazubskaya T, Garkavtseva R, Zabarovska VI, Kashuba VI, Kisselev LL, Minna JD, Lerman MI, Klein G, et al. Discovery of frequent homozygous deletions in chromosome 3p21.3 LUCA and AP20 regions in renal, lung and breast carcinomas. Oncogene. 23: 5719-28. PMID 15208675 DOI: 10.1038/Sj.Onc.1207760  0.306
2004 Kost-Alimova M, Fedorova L, Yang Y, Klein G, Imreh S. Microcell-mediated chromosome transfer provides evidence that polysomy promotes structural instability in tumor cell chromosomes through asynchronous replication and breakage within late-replicating regions Genes Chromosomes and Cancer. 40: 316-324. PMID 15188454 DOI: 10.1002/Gcc.20054  0.384
2004 Kashuba VI, Li J, Wang F, Senchenko VN, Protopopov A, Malyukova A, Kutsenko AS, Kadyrova E, Zabarovska VI, Muravenko OV, Zelenin AV, Kisselev LL, Kuzmin I, Minna JD, Winberg G, ... ... Klein G, et al. RBSP3 (HYA22) is a tumor suppressor gene implicated in major epithelial malignancies. Proceedings of the National Academy of Sciences of the United States of America. 101: 4906-11. PMID 15051889 DOI: 10.1073/Pnas.0401238101  0.354
2004 Klein G, Ohno S, Rosenberg N, Wiener F, Spira J, Baltimore D. Cytogenetic studies on abelson-virus-induced mouse leukemias. International Journal of Cancer. 25: 805-11. PMID 14768711 DOI: 10.1002/Ijc.2910250617  0.42
2004 Gunvén P, Klein G, Klein E, Norin T, Singh S. Surface immunoglobulins on Burkitt's lymphoma biopsy cells from 91 patients. International Journal of Cancer. 25: 711-9. PMID 14768699 DOI: 10.1002/Ijc.2910250605  0.333
2004 Nishikawa J, Kis LL, Liu A, Zhang X, Takahara M, Bandobashi K, Kiss C, Nagy N, Okita K, Klein G, Klein E. Upregulation of LMP1 Expression by Histone Deacetylase Inhibitors in an EBV Carrying NPC Cell Line Virus Genes. 28: 121-128. PMID 14739656 DOI: 10.1023/B:Viru.0000012268.35297.Ff  0.411
2003 Imreh S, Klein G, Zabarovsky ER. Search for Unknown Tumor-Antagonizing Genes Genes Chromosomes and Cancer. 38: 307-321. PMID 14566849 DOI: 10.1002/Gcc.10271  0.342
2003 Nishikawa J, Kiss C, Imai S, Takada K, Okita K, Klein G, Szekely L. Upregulation of the truncated basic hair keratin 1(hHb1-ΔN) in carcinoma cells by Epstein-Barr virus (EBV) International Journal of Cancer. 107: 597-602. PMID 14520698 DOI: 10.1002/Ijc.11289  0.409
2003 Drotar ME, Silva S, Barone E, Campbell D, Tsimbouri P, Jurvansu J, Bhatia P, Klein G, Wilson JB. Epstein-Barr virus nuclear antigen-1 and Myc cooperate in lymphomagenesis. International Journal of Cancer. 106: 388-95. PMID 12845679 DOI: 10.1002/Ijc.11224  0.389
2003 Kashuba E, Mattsson K, Pokrovskaja K, Kiss C, Protopopova M, Ehlin-Henriksson B, Klein G, Szekely L. EBV-encoded EBNA-5 associates with P14ARF in extranucleolar inclusions and prolongs the survival of P14ARF-expressing cells. International Journal of Cancer. 105: 644-53. PMID 12740913 DOI: 10.1002/Ijc.11124  0.378
2003 Kost-Alimova M, Kiss H, Fedorova L, Yang Y, Dumanski JP, Klein G, Imreh S. Coincidence of synteny breakpoints with malignancy-related deletions on human chromosome 3. Proceedings of the National Academy of Sciences of the United States of America. 100: 6622-7. PMID 12738884 DOI: 10.1073/Pnas.0430971100  0.341
2003 Kiss C, Nishikawa J, Takada K, Trivedi P, Klein G, Szekely L. T cell leukemia I oncogene expression depends on the presence of Epstein-Barr virus in the virus-carrying Burkitt lymphoma lines. Proceedings of the National Academy of Sciences of the United States of America. 100: 4813-8. PMID 12672960 DOI: 10.1073/Pnas.0730710100  0.403
2003 Ehlin-Henriksson B, Gordon J, Klein G. B-lymphocyte subpopulations are equally susceptible to Epstein-Barr virus infection, irrespective of immunoglobulin isotype expression. Immunology. 108: 427-30. PMID 12667203 DOI: 10.1046/J.1365-2567.2003.01601.X  0.396
2003 Yamasaki T, Moritake K, Klein G. Experimental appraisal of the lack of antitumor natural killer cell-mediated immunosurveillance in response to lymphomas growing in the mouse brain. Journal of Neurosurgery. 98: 599-606. PMID 12650434 DOI: 10.3171/Jns.2003.98.3.0599  0.418
2003 Yang Y, Li J, Szeles A, Imreh MP, Kost-Alimova M, Kiss H, Kholodnyuk I, Fedorova L, Darai E, Klein G, Imreh S. Consistent downregulation of human lactoferrin gene, in the common eliminated region 1 on 3p21.3, following tumor growth in severe combined immunodeficient (SCID) mice. Cancer Letters. 191: 155-64. PMID 12618328 DOI: 10.1016/S0304-3835(02)00677-8  0.34
2003 Kis LL, Nagy N, Klein G, Klein E. Expression of SH2D1A in five classical Hodgkin's disease-derived cell lines International Journal of Cancer. 104: 658-661. PMID 12594824 DOI: 10.1002/Ijc.10986  0.423
2003 Kiss C, Nishikawa J, Dieckmann A, Takada K, Klein G, Szekely L. Improved subtractive suppression hybridization combined with high density cDNA array screening identifies differentially expressed viral and cellular genes. Journal of Virological Methods. 107: 195-203. PMID 12505634 DOI: 10.1016/S0166-0934(02)00233-1  0.339
2002 Kashuba E, Kashuba V, Sandalova T, Klein G, Szekely L. Epstein-Barr virus encoded nuclear protein EBNA-3 binds a novel human uridine kinase/uracil phosphoribosyltransferase. Bmc Cell Biology. 3: 23. PMID 12199906 DOI: 10.1186/1471-2121-3-23  0.406
2002 Protopopov AI, Li J, Winberg G, Gizatullin RZ, Kashuba VI, Klein G, Zabarovsky ER. Human cell lines engineered for tetracycline-regulated expression of tumor suppressor candidate genes from a frequently affected chromosomal region, 3p21 Journal of Gene Medicine. 4: 397-406. PMID 12124982 DOI: 10.1002/Jgm.283  0.401
2002 Braga E, Senchenko V, Bazov I, Loginov W, Liu J, Ermilova V, Kazubskaya T, Garkavtseva R, Mazurenko N, Kisseljov F, Lerman MI, Klein G, Kisselev L, Zabarovsky ER. Critical tumor-suppressor gene regions on chromosome 3P in major human epithelial malignancies: allelotyping and quantitative real-time PCR. International Journal of Cancer. Journal International Du Cancer. 100: 534-41. PMID 12124802 DOI: 10.1002/Ijc.10511  0.311
2002 Nagy N, Maeda A, Bandobashi K, Kis LL, Nishikawa J, Trivedi P, Faggioni A, Klein G, Klein E. SH2D1A expression in Burkitt lymphoma cells is restricted to EBV positive group I lines and is downregulated in parallel with immunoblastic transformation. International Journal of Cancer. 100: 433-440. PMID 12115526 DOI: 10.1002/Ijc.10498  0.44
2002 Pokrovskaja K, Ehlin-Henriksson B, Kiss C, Challa A, Gordon J, Gogolak P, Klein G, Szekely L. CD40 ligation downregulates EBNA-2 and LMP-1 expression in EBV-transformed lymphoblastoid cell lines International Journal of Cancer. 99: 705-712. PMID 12115504 DOI: 10.1002/Ijc.10417  0.396
2002 Kassis J, Maeda A, Teramoto N, Takada K, Wu C, Klein G, Wells A. EBV-expressing AGS gastric carcinoma cell sublines present increased motility and invasiveness. International Journal of Cancer. 99: 644-51. PMID 12115496 DOI: 10.1002/Ijc.10382  0.49
2002 Kiss H, Yang Y, Kiss C, Andersson K, Klein G, Imreh S, Dumanski JP. The transcriptional map of the common eliminated region 1 (C3CER1) in 3p21.3. European Journal of Human Genetics. 10: 52-61. PMID 11896456 DOI: 10.1038/Sj.Ejhg.5200758  0.3
2002 Klein G, Powers A, Croce C. Association of SV40 with human tumors. Oncogene. 21: 1141-9. PMID 11850833 DOI: 10.1038/Sj.Onc.1205173  0.315
2002 Liu A, Klein G, Bandobashi K, Klein E, Nagy N. SH2D1A expression reflects activation of T and NK cells in cord blood lymphocytes infected with EBV and treated with the immunomodulator PSK Immunology Letters. 80: 181-188. PMID 11803050 DOI: 10.1016/S0165-2478(01)00330-3  0.368
2002 Mattsson K, Kiss C, Platt GM, Simpson GR, Kashuba E, Klein G, Schulz TF, Szekely L. Latent nuclear antigen of Kaposi's sarcoma herpesvirus/human herpesvirus-8 induces and relocates RING3 to nuclear heterochromatin regions. The Journal of General Virology. 83: 179-88. PMID 11752715 DOI: 10.1099/0022-1317-83-1-179  0.402
2002 Klein G. Perspectives in studies of human tumor viruses. Frontiers in Bioscience. 7. DOI: 10.2741/Klein  0.397
2001 Bandobashi K, Maeda A, Teramoto N, Nagy N, Székely L, Taguchi H, Miyoshi I, Klein G, Klein E. Intranuclear localization of the transcription coadaptor CBP/p300 and the transcription factor RBP-Jk in relation to EBNA-2 and -5 in B lymphocytes. Virology. 288: 275-82. PMID 11601899 DOI: 10.1006/Viro.2001.1103  0.358
2001 Maeda A, Kiss C, Chen F, Ehlin-Henriksson B, Nagy N, Szekely L, Takada K, Klein E, Klein G. EBNA promoter usage in EBV-negative Burkitt lymphoma cell lines converted with a neomycin-resistant EBV strain. International Journal of Cancer. 93: 714-9. PMID 11477584 DOI: 10.1002/Ijc.1387  0.397
2001 Dreijerink K, Braga E, Kuzmin I, Geil L, Duh FM, Angeloni D, Zbar B, Lerman MI, Stanbridge EJ, Minna JD, Protopopov A, Li J, Kashuba V, Klein G, Zabarovsky ER. The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis. Proceedings of the National Academy of Sciences of the United States of America. 98: 7504-9. PMID 11390984 DOI: 10.1073/Pnas.131216298  0.326
2001 Pokrovskaja K, Mattsson K, Kashuba E, Klein G, Szekely L. Proteasome inhibitor induces nucleolar translocation of Epstein-Barr virus-encoded EBNA-5. The Journal of General Virology. 82: 345-358. PMID 11161273 DOI: 10.1099/0022-1317-82-2-345  0.354
2000 Linardopoulos S, Silva S, Klein G, Balmain A. Allele-specific loss or imbalance of chromosomes 9, 15, and 16 in B-cell tumors from interspecific F1 hybrid mice carrying Eμ-c-myc or N-myc transgenes International Journal of Cancer. 88: 920-927. PMID 11093815 DOI: 10.1002/1097-0215(20001215)88:6<920::Aid-Ijc13>3.0.Co;2-#  0.349
2000 Nagy N, Cerboni C, Mattsson K, Maeda A, Gogolák P, Sümegi J, Lányi Á, Székely L, Carbone E, Klein G, Klein E. SH2D1A and SLAM protein expression in human lymphocytes and derived cell lines. International Journal of Cancer. 88: 439-447. PMID 11054674 DOI: 10.1002/1097-0215(20001101)88:3<439::Aid-Ijc17>3.0.Co;2-#  0.426
2000 Nagy N, Cerboni C, Mattsson K, Maeda A, Gogolák P, Sümegi J, Lányi A, Székely L, Carbone E, Klein G, Klein E. SH2D1A and SLAM protein expression in human lymphocytes and derived cell lines. International Journal of Cancer. 88: 439-47. PMID 11054674 DOI: 10.1002/1097-0215(20001101)88:3<439::AID-IJC17>3.0.CO;2  0.313
2000 Klein G. Simian virus 40 and the human mesothelium Proceedings of the National Academy of Sciences of the United States of America. 97: 9830-9831. PMID 10954758 DOI: 10.1073/Pnas.190325697  0.358
2000 Kashuba V, Protopopov A, Podowski R, Gizatullin R, Li J, Klein G, Wahlestedt C, Zabarovsky E. Isolation and chromosomal localization of a new human retinoblastoma binding protein 2 homologue 1a (RBBP2H1A). European Journal of Human Genetics : Ejhg. 8: 407-13. PMID 10878660 DOI: 10.1038/Sj.Ejhg.5200474  0.301
2000 Klein G. Dysregulation of lymphocyte proliferation by chromosomal translocations and sequential genetic changes Bioessays. 22: 414-422. PMID 10797481 DOI: 10.1002/(Sici)1521-1878(200005)22:5<414::Aid-Bies3>3.0.Co;2-5  0.391
2000 Kashuba E, Kashuba V, Pokrovskaja K, Klein G, Szekely L. Epstein-Barr virus encoded nuclear protein EBNA-3 binds XAP-2, a protein associated with Hepatitis B virus X antigen. Oncogene. 19: 1801-1806. PMID 10777214 DOI: 10.1038/Sj.Onc.1203501  0.395
2000 Teramoto N, Maeda A, Kobayashi K, Hayashi K, Oka T, Takahashi K, Takada K, Klein G, Akagi T. Epstein-Barr Virus Infection to Epstein-Barr Virus-Negative Nasopharyngeal Carcinoma Cell Line TW03 Enhances Its Tumorigenicity Laboratory Investigation. 80: 303-312. PMID 10744066 DOI: 10.1038/Labinvest.3780035  0.348
2000 Zabarovska V, Li J, Muravenko O, Fedorova L, Braga E, Ernberg I, Wahlestedt C, Klein G, Zabarovsky ER. CIS--cloning of identical sequences between two complex genomes. Chromosome Research : An International Journal On the Molecular, Supramolecular and Evolutionary Aspects of Chromosome Biology. 8: 77-84. PMID 10730592 DOI: 10.1023/A:1009243606611  0.307
2000 Alimov A, Kost-Alimova M, Liu J, Li C, Bergerheim U, Imreh S, Klein G, Zabarovsky ER. Combined LOH/CGH analysis proves the existence of interstitial 3p deletions in renal cell carcinoma. Oncogene. 19: 1392-9. PMID 10723130 DOI: 10.1038/Sj.Onc.1203449  0.334
2000 Trivedi P, Cuomo L, Christensson B, Hu LF, Morrone S, Frati L, Faggioni A, Winberg G, Klein G. Augmentation of leukocyte infiltration in murine tumors expressing B-cell derived but not nasopharyngeal carcinoma derived EBV membrane protein LMP1. Journal of Medical Virology. 60: 417-24. PMID 10686025 DOI: 10.1002/(Sici)1096-9071(200004)60:4<417::Aid-Jmv9>3.0.Co;2-O  0.391
1999 Yang Y, Kiss H, Kost-Alimova M, Kedra D, Fransson I, Seroussi E, Li J, Szeles A, Kholodnyuk I, Imreh MP, Fodor K, Hadlaczky G, Klein G, Dumanski JP, Imreh S. A 1-Mb PAC contig spanning the common eliminated region 1 (CER1) in microcell hybrid-derived SCID tumors. Genomics. 62: 147-155. PMID 10610706 DOI: 10.1006/Geno.1999.5952  0.328
1999 Szekely L, Kiss C, Mattsson K, Kashuba E, Pokrovskaja K, Juhasz A, Holmvall P, Klein G. Human herpesvirus-8-encoded LNA-1 accumulates in heterochromatin- associated nuclear bodies. The Journal of General Virology. 80: 2889-2900. PMID 10580050 DOI: 10.1099/0022-1317-80-11-2889  0.386
1999 Ehlin-Henriksson B, Zou JZ, Klein G, Ernberg I. Epstein-Barr virus genomes are found predominantly in IgA-positive B cells in the blood of healthy carriers. International Journal of Cancer. 83: 50-4. PMID 10449607 DOI: 10.1002/(Sici)1097-0215(19990924)83:1<50::Aid-Ijc10>3.0.Co;2-1  0.387
1999 Li J, Protopopov AI, Gizatullin RZ, Kiss C, Kashuba VI, Winberg G, Klein G, Zabarovsky ER. Identification of new tumor suppressor genes based on in vivo functional inactivation of a candidate gene. Febs Letters. 451: 289-94. PMID 10371207 DOI: 10.1016/S0014-5793(99)00598-0  0.31
1999 Teramoto N, Pokrovskaja K, Szekely L, Polack A, Yoshino T, Akagi T, Klein G. Expression of cyclin D2 and D3 in lymphoid lesions. International Journal of Cancer. 81: 543-50. PMID 10225442 DOI: 10.1002/(Sici)1097-0215(19990517)81:4<543::Aid-Ijc7>3.0.Co;2-3  0.332
1999 Szeles A, Falk KI, Imreh S, Klein G. Visualization of Alternative Epstein-Barr Virus Expression Programs by Fluorescent In Situ Hybridization at the Cell Level Journal of Virology. 73: 5064-5069. DOI: 10.1128/Jvi.73.6.5064-5069.1999  0.394
1998 Magnusson KP, Satalino R, Qian W, Klein G, Wiman KG. Is conversion of solid into more anoxic ascites tumors associated with p53 inactivation? Oncogene. 17: 2333-7. PMID 9811464 DOI: 10.1038/Sj.Onc.1202149  0.33
1998 Klein G, Klein E. Sinking surveillance's flagship Nature. 395: 441-443. PMID 9774094 DOI: 10.1038/26626  0.368
1998 Teramoto N, Szekely L, Pokrovskaja K, Hu LF, Yoshino T, Akagi T, Klein G. Simultaneous detection of two independent antigens by double staining with two mouse monoclonal antibodies. Journal of Virological Methods. 73: 89-97. PMID 9705180 DOI: 10.1016/S0166-0934(98)00048-2  0.374
1998 Szekely L, Chen F, Teramoto N, Ehlin-Henriksson B, Pokrovskaja K, Szeles A, Manneborg-Sandlund A, Löwbeer M, Lennette ET, Klein G. Restricted expression of Epstein-Barr virus (EBV)-encoded, growth transformation-associated antigens in an EBV- and human herpesvirus type 8-carrying body cavity lymphoma line. The Journal of General Virology. 1445-52. PMID 9634087 DOI: 10.1099/0022-1317-79-6-1445  0.461
1998 Laytragoon-Lewin N, Kashuba V, Mellstedt H, Klein G. bcl-2 rearrangement detected by pulsed-field gel electrophoresis (PFGF) in B-chronic lymphocytic leukemia (CLL) cells. International Journal of Cancer. 76: 909-12. PMID 9626361 DOI: 10.1002/(Sici)1097-0215(19980610)76:6<909::Aid-Ijc23>3.0.Co;2-W  0.406
1998 Mukherjee S, Trivedi P, Dorfman DM, Klein G, Townsend A. Murine cytotoxic T lymphocytes recognize an epitope in an EBNA-1 fragment, but fail to lyse EBNA-1-expressing mouse cells. The Journal of Experimental Medicine. 187: 445-50. PMID 9449725 DOI: 10.1084/Jem.187.3.445  0.452
1998 Szeles A, Yang Y, Sandlund AM, Kholodnyuk I, Kiss H, Kost-Alimova M, Zabarovsky ER, Stanbridge E, Klein G, Imreh S. Human/mouse microcell hybrid based elimination test reduces the putative tumor suppressor region at 3p21.3 to 1.6 cM. Genes, Chromosomes & Cancer. 20: 329-36. PMID 9408748 DOI: 10.1002/(Sici)1098-2264(199712)20:4<329::Aid-Gcc3>3.0.Co;2-3  0.323
1998 Klein G. Foulds' dangerous idea revisited: the multistep development of tumors 40 years later. Advances in Cancer Research. 72: 1-23. PMID 9338072 DOI: 10.1016/S0065-230X(08)60698-3  0.307
1997 Imreh S, Kost-Alimova M, Kholodnyuk I, Yang Y, Szeles A, Kiss H, Liu Y, Foster K, Zabarovsky E, Stanbridge E, Klein G. Differential elimination of 3p and retention of 3q segments in human/mouse microcell hybrids during tumor growth Genes Chromosomes and Cancer. 20: 224-233. PMID 9365829 DOI: 10.1002/(Sici)1098-2264(199711)20:3<224::Aid-Gcc2>3.0.Co;2-4  0.323
1997 Wen T, Kono K, Shahinian A, Kiessling R, Mak TW, Klein G. CD28 is not required for rejection of unmanipulated syngeneic and autologous tumors. European Journal of Immunology. 27: 1988-93. PMID 9295036 DOI: 10.1002/Eji.1830270824  0.316
1997 Trivedi P, Winberg G, Klein G. Differential immunogenicity of Epstein-Barr virus (EBV) encoded growth transformation-associated antigens in a murine model system. European Journal of Cancer (Oxford, England : 1990). 33: 912-7. PMID 9291815 DOI: 10.1016/S0959-8049(96)00514-X  0.315
1997 Pokrovskaja K, Trivedi P, Klein G, Szekely L. Epstein-Barr virus-encoded LMP-1 protein upregulates the pNDCF group of nucleoskeleton-cytoskeleton-associated proteins. The Journal of General Virology. 2031-40. PMID 9267004 DOI: 10.1099/0022-1317-78-8-2031  0.41
1997 Wiman KG, Klein G. An old acquaintance resurfaces in human mesothelioma. Nature Medicine. 3: 839-40. PMID 9256272 DOI: 10.1038/Nm0897-839  0.36
1997 Enblad G, Sandvej K, Lennette E, Sundström C, Klein G, Glimelius B, Pallesen G. Lack of correlation between EBV serology and presence of EBV in the Hodgkin and Reed-Sternberg cells of patients with Hodgkin's disease. International Journal of Cancer. 72: 394-7. PMID 9247279 DOI: 10.1002/(Sici)1097-0215(19970729)72:3<394::Aid-Ijc3>3.0.Co;2-K  0.304
1997 Klein G. Rejection antigens in chemically induced tumors Proceedings of the National Academy of Sciences of the United States of America. 94: 5991-5992. PMID 9177154 DOI: 10.1073/Pnas.94.12.5991  0.378
1997 Laytragoon-Lewin N, Chen F, Avila-Carino J, Klein G, Mellstedt H. Epstein-Barr virus (EBV) gene expression in lymphoid B cells during acute infectious mononucleosis (IM) and clonality of the directly growing cell lines. International Journal of Cancer. 71: 345-9. PMID 9139865 DOI: 10.1002/(Sici)1097-0215(19970502)71:3<345::Aid-Ijc6>3.0.Co;2-Y  0.44
1997 Lanyi A, Li B, Li S, Talmadge CB, Brichacek B, Davis JR, Kozel BA, Trask B, van den Engh G, Uzvolgyi E, Stanbridge EJ, Nelson DL, Chinault C, Heslop H, Gross TG, ... ... Klein G, et al. A yeast artificial chromosome (YAC) contig encompassing the critical region of the X-linked lymphoproliferative disease (XLP) locus. Genomics. 39: 55-65. PMID 9027486 DOI: 10.1006/Geno.1996.4466  0.327
1997 Jiang WQ, Szekely L, Klein G, Ringertz N. Intranuclear redistribution of SV40T, p53, and PML in a conditionally SV40T-immortalized cell line. Experimental Cell Research. 229: 289-300. PMID 8986612 DOI: 10.1006/Excr.1996.0374  0.35
1997 Avila-Cariño J, Lewin N, Tomita Y, Szeles A, Sandlund A, Mosolits S, Mellstedt H, Klein G, Klein E. B-CLL cells with unusual properties. International Journal of Cancer. 70: 1-8. PMID 8985083 DOI: 10.1002/(Sici)1097-0215(19970106)70:1<1::Aid-Ijc1>3.0.Co;2-1  0.437
1997 Silva S, Babonits M, Klein G. Ig/myc translocations of the plasmacytoma-prone BALB/c strain occur independently of the genetic and parental origin of the affected chromosomes 6, 12, and 15. Genes, Chromosomes & Cancer. 17: 179-84. PMID 8946197 DOI: 10.1002/(Sici)1098-2264(199611)17:3<179::Aid-Gcc6>3.0.Co;2-1  0.318
1996 KLEIN G, KLEIN E. ANTIGENIC BEHAVIOR OF MOLONEY LYMPHOMAS: INDEPENDENCE OV VIRUS RELEASE AND IMMUNOSENSITIVITY. Science (New York, N.Y.). 145: 1316-7. PMID 14173420 DOI: 10.1126/Science.145.3638.1316  0.376
1996 Yamasaki T, Akiyama Y, Fukuda M, Kimura Y, Moritake K, Kikuchi H, Ljunggren H, Kärre K, Klein G. Natural Resistance Against Tumors Grafted Into The Brain In Association With Histocompatibility-Class-I-Antigen Expression International Journal of Cancer. 67: 365-371. PMID 8707410 DOI: 10.1002/(Sici)1097-0215(19960729)67:3<365::Aid-Ijc10>3.0.Co;2-7  0.399
1996 Contreras-Brodin B, Karlsson A, Nilsson T, Rymo L, Klein G. B cell-specific activation of the Epstein-Barr virus-encoded C promoter compared with the wide-range activation of the W promoter. The Journal of General Virology. 1159-62. PMID 8683201 DOI: 10.1099/0022-1317-77-6-1159  0.403
1995 Wennborg A, Classon M, Klein G, Gabain Av. Downregulation of c-myc expression after heat shock in human B-cell lines is independent of 5' mRNA sequences. Biological Chemistry Hoppe-Seyler. 376: 671-680. PMID 8962676 DOI: 10.1515/Bchm3.1995.376.11.671  0.323
1995 Sugiyama H, Silva S, Wang Y, Klein G. Strain-related cellular mechanisms as a determinant for susceptibility and resistance to PC induction. Current Topics in Microbiology and Immunology. 194: 93-7. PMID 7895526 DOI: 10.1007/978-3-642-79275-5_12  0.309
1995 Chen F, Hu LF, Ernberg I, Klein G, Winberg G. Coupled transcription of Epstein-Barr virus latent membrane protein (LMP)-1 and LMP-2B genes in nasopharyngeal carcinomas. The Journal of General Virology. 131-8. PMID 7844522 DOI: 10.1099/0022-1317-76-1-131  0.346
1995 Szekely L, Wang Y, Klein G, Wiman KG. RB-reconstituted human retinoblastoma cells form RB-positive intraocular and intracerebral but not subcutaneous tumors in SCID mice. International Journal of Cancer. 61: 683-91. PMID 7768642 DOI: 10.1002/Ijc.2910610516  0.402
1995 Lewin N, Avila-Cariño J, Minarovits J, Lennette E, Brautbar C, Mellstedt H, Klein G, Klein E. Detection of two Epstein-Barr-virus (EBV)-carrying leukemic cell clones in a patient with chronic lymphocytic leukemia (CLL). International Journal of Cancer. 61: 159-64. PMID 7705941 DOI: 10.1002/Ijc.2910610203  0.459
1995 Imreh MP, Zhang QJ, de Campos-Lima PO, Imreh S, Krausa P, Browning M, Klein G, Masucci MG. Mechanisms of allele-selective down-regulation of HLA class I in Burkitt's lymphoma. International Journal of Cancer. Journal International Du Cancer. 62: 90-6. PMID 7601573 DOI: 10.1002/Ijc.2910620117  0.317
1995 Szekely L, Jiang WQ, Pokrovskaja K, Wiman KG, Klein G, Ringertz N. Reversible nucleolar translocation of Epstein-Barr virus-encoded EBNA-5 and hsp70 proteins after exposure to heat shock or cell density congestion. The Journal of General Virology. 2423-32. PMID 7595346 DOI: 10.1099/0022-1317-76-10-2423  0.372
1995 Laytragoon-Lewin N, Chen F, Avila-Cariño J, Zou JZ, Mellstedt H, Ernberg I, Klein G. Epstein Barr virus (EBV)-carrying cells of a chronic lymphocytic leukemia (CLL) subpopulation express EBNA1 and LMPs but not EBNA2 in vivo. International Journal of Cancer. 63: 486-90. PMID 7591254 DOI: 10.1002/Ijc.2910630404  0.444
1995 Magnusson KP, Minarovits J, Klein G, Wiman KG. A splice donor site mutation results in the insertion of five extra amino acids into P53 from SEWA mouse sarcoma cells. Gene. 162: 231-4. PMID 7557434 DOI: 10.1016/0378-1119(95)00338-7  0.301
1995 Stuber G, Dillner J, Modrow S, Wolf H, Székely L, Klein G, Klein E. HLA-A0201 and HLA-B7 binding peptides in the EBV-encoded EBNA-1, EBNA-2 and BZLF-1 proteins detected in the MHC class I stabilization assay. Low proportion of binding motifs for several HLA class I alleles in EBNA-1. International Immunology. 7: 653-63. PMID 7547693 DOI: 10.1093/Intimm/7.4.653  0.305
1995 Levitskaya J, Coram M, Levitsky V, Imreh S, Steigerwald-Mullen PM, Klein G, Kurilla MG, Masucci MG. Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1 Nature. 375: 685-688. PMID 7540727 DOI: 10.1038/375685A0  0.408
1995 Axelson H, Wang Y, Silva S, Mattei MG, Klein G. Juxtaposition of N-myc and Ig kappa through a reciprocal t(6;12) translocation in a mouse plasmacytoma. Genes, Chromosomes & Cancer. 11: 85-90. PMID 7529553 DOI: 10.1002/Gcc.2870110204  0.359
1995 Orsini DL, van Gils M, Kooy YM, Struyk L, Klein G, van den Elsen P, Koning F. Functional and molecular characterization of B cell-responsive V delta 1+ gamma delta T cells. European Journal of Immunology. 24: 3199-204. PMID 7528674 DOI: 10.1002/Eji.1830241243  0.395
1995 Chen F, Zou JZ, di Renzo L, Winberg G, Hu LF, Klein E, Klein G, Ernberg I. A subpopulation of normal B cells latently infected with Epstein-Barr virus resembles Burkitt lymphoma cells in expressing EBNA-1 but not EBNA-2 or LMP1. Journal of Virology. 69: 3752-3758. DOI: 10.1128/Jvi.69.6.3752-3758.1995  0.318
1995 Klein U, Klein G, Ehlin-Henriksson B, Rajewsky K, Küppers R. Burkitt’s Lymphoma Is a Malignancy of Mature B Cells Expressing Somatically Mutated V Region Genes Molecular Medicine. 1: 495-505. DOI: 10.1007/Bf03401587  0.363
1994 Axelson H, Panda CK, Klein G. Three exceptional IgH/myc-translocation-carrying rat immunocytomas have breakpoints 50 to 80 kb 5' of c-myc. International Journal of Cancer. 56: 418-21. PMID 8314330 DOI: 10.1002/Ijc.2910560322  0.302
1994 Renzo Ld, Alttok A, Klein G, Klein E. Endogenous TGF-β contributes to the induction of the EBV lytic cycle in two burkitt lymphoma cell lines International Journal of Cancer. 57: 914-919. PMID 8206684 DOI: 10.1002/Ijc.2910570623  0.38
1994 Minarovits J, Hu LF, Minarovits-Kormuta S, Klein G, Ernberg I. Sequence-specific methylation inhibits the activity of the Epstein-Barr virus LMP 1 and BCR2 enhancer-promoter regions. Virology. 200: 661-7. PMID 8178450 DOI: 10.1006/Viro.1994.1229  0.306
1994 Trivedi P, Hu LF, Chen F, Christensson B, Masucci MG, Klein G, Winberg G. Epstein-Barr virus (EBV)-encoded membrane protein LMP1 from a nasopharyngeal carcinoma is non-immunogenic in a murine model system, in contrast to a B cell-derived homologue. European Journal of Cancer (Oxford, England : 1990). 84-8. PMID 8142171 DOI: 10.1016/S0959-8049(05)80024-3  0.309
1994 Sugiyama H, Wang Y, Jackson P, Sawyers CL, Klein G. Molecular requirements for rapid plasmacytoma and pre-B lymphoma induction by Abelson murine leukemia virus in myc-transgenic mice. International Journal of Cancer. 58: 135-41. PMID 8014009 DOI: 10.1002/Ijc.2910580122  0.362
1994 Klein G. Epstein-Barr virus strategy in normal and neoplastic B cells Cell. 77: 791-793. PMID 8004668 DOI: 10.1016/0092-8674(94)90125-2  0.39
1994 Zheng X, Yuan F, Hu L, Chen F, Klein G, Christensson B. Effect of B‐lymphocyte‐ and NPC‐derived EBV‐1 gene expression on in vitro growth and differentiation of human epithelial cells International Journal of Cancer. 57: 747-753. PMID 7910811 DOI: 10.1002/Ijc.2910570523  0.391
1994 Klein G. Role of EBV and Ig/myc translocation in Burkitt lymphoma. Antibiotics and Chemotherapy. 46: 110-116. PMID 7826031 DOI: 10.1159/000423638  0.331
1993 Yamasaki T, Klein G, Ljunggren HG, Kärre K, Moritake K, Paine JT, Kikuchi H. Role of histocompatibility antigen gene and protooncogene expressions in intracerebral tumorigenicity of mouse neuroblastoma. Journal of Neurosurgery. 78: 619-29. PMID 8450336 DOI: 10.3171/Jns.1993.78.4.0619  0.392
1993 Trivedi P, Cuomo L, de Campos-Lima PO, Imreh MP, Kvarnung K, Klein G, Masucci MG. Integration of a short Epstein-Barr virus DNA fragment in a B95-8 virus converted Burkitt lymphoma line expressing Epstein-Barr nuclear antigens EBNA2 and EBNA5. The Journal of General Virology. 1393-8. PMID 8393080 DOI: 10.1099/0022-1317-74-7-1393  0.43
1993 Fåhraeus R, Jansson A, Sjöblom A, Nilsson T, Klein G, Rymo L. Cell phenotype-dependent control of Epstein-Barr virus latent membrane protein 1 gene regulatory sequences. Virology. 195: 71-80. PMID 8391188 DOI: 10.1006/Viro.1993.1347  0.402
1993 Cuomo L, Zhang QJ, Lombardi L, Torsteinsdottir S, Klein G, Dalla-Favera R, Masucci MG. Over-expression of c-myc increases the sensitivity of Epstein-Barr virus immortalized lymphoblastoid cells to non-MHC-restricted cytotoxicity International Journal of Cancer. 53: 1008-1012. PMID 8386135 DOI: 10.1002/Ijc.2910530625  0.426
1993 de Campos-Lima PO, Torsteinsdóttir S, Cuomo L, Klein G, Sulitzeanu D, Masucci MG. Antigen processing and presentation by EBV-carrying cell lines: cell-phenotype dependence and influence of the EBV-encoded LMP1. International Journal of Cancer. 53: 856-62. PMID 8383631 DOI: 10.1002/Ijc.2910530525  0.407
1993 Zabarovsky ER, Kashuba VI, Pokrovskaya ES, Zabarovska VI, Wang JY, Berglund P, Boldog F, Stanbridge EJ, Sumegi J, Klein G. Alu-PCR approach to isolating NotI-linking clones from the 3p14-p21 region frequently deleted in renal cell carcinoma. Genomics. 16: 713-9. PMID 8325645 DOI: 10.1006/Geno.1993.1252  0.329
1993 Klein G. Multistep evolution of B-cell-derived tumors in humans and rodents Gene. 135: 189-196. PMID 8276258 DOI: 10.1016/0378-1119(93)90065-B  0.397
1993 Classon M, Wennborg A, Henriksson M, Klein G. Analysis of c-Myc domains involved in stimulating SV40 replication. Gene. 133: 153-61. PMID 8224903 DOI: 10.1016/0378-1119(93)90633-E  0.322
1993 Lennette ET, Rymo L, Yadav M, Masucci G, Merk K, Timar L, Klein G. Disease-related differences in antibody patterns against EBV-encoded nuclear antigens EBNA 1, EBNA 2 and EBNA 6. European Journal of Cancer (Oxford, England : 1990). 29: 1584-9. PMID 8217366 DOI: 10.1016/0959-8049(93)90299-U  0.328
1993 Dedeoglu F, Kaymaz H, Klein G, Marchalonis JJ. Light and heavy chains specifying a human IgMκ autoantibody to a T-cell receptor Vβ-antigen Immunology Letters. 38: 223-227. PMID 8125530 DOI: 10.1016/0165-2478(93)90010-Y  0.357
1993 Szekely L, Jin P, Jiang WQ, Rosén A, Wiman KG, Klein G, Ringertz N. Position-dependent nuclear accumulation of the retinoblastoma (RB) protein during in vitro myogenesis. Journal of Cellular Physiology. 155: 313-22. PMID 7683311 DOI: 10.1002/Jcp.1041550212  0.342
1993 Cuomo L, Trivedi P, de Campos-Lima PO, Zhang QJ, Ragnar E, Klein G, Masucci MG. Selective induction of allostimulatory capacity after 5-azaC treatment of EBV carrying but not EBV negative Burkitt lymphoma cell lines. Molecular Immunology. 30: 441-50. PMID 7681932 DOI: 10.1016/0161-5890(93)90112-O  0.404
1993 Henriksson M, Classon M, Axelson H, Klein G, Thyberg J. Nuclear colocalization of c-myc protein and hsp70 in cells transfected with human wild-type and mutant c-myc genes. Experimental Cell Research. 203: 383-94. PMID 1459202 DOI: 10.1016/0014-4827(92)90012-W  0.333
1992 Boldog F, Arheden K, Imreh S, Strömbeck B, Szekely L, Erlandsson R, Marcsek Z, Sumegi J, Mitelman F, Klein G. Involvement of 3p deletions in sporadic and hereditary forms of renal cell carcinoma. Genes, Chromosomes & Cancer. 3: 403-6. PMID 1797089 DOI: 10.1002/Gcc.2870030513  0.359
1992 Zabarovsky ER, Boldog F, Erlandsson R, Kashuba VI, Allikmets RL, Marcsek Z, Kisselev LL, Stanbridge E, Klein G, Sumegi J. New strategy for mapping the human genome based on a novel procedure for construction of jumping libraries. Genomics. 11: 1030-9. PMID 1783374 DOI: 10.1016/0888-7543(91)90029-E  0.316
1992 Wennborg AD, Altiok E, Moore JP, Ernberg I, Klein G. Differential c-myc protein expression in Burkitt's lymphomas and EBV-transformed lymphoblastoid lines. European Journal of Cancer (Oxford, England : 1990). 27: 1643-5. PMID 1782076 DOI: 10.1016/0277-5379(91)90436-H  0.397
1992 Contreras-Brodin BA, Anvret M, Imreh S, Altiok E, Klein G, Masucci MG. B cell phenotype-dependent expression of the Epstein-Barr virus nuclear antigens EBNA-2 to EBNA-6: studies with somatic cell hybrids. The Journal of General Virology. 3025-33. PMID 1662694 DOI: 10.1099/0022-1317-72-12-3025  0.445
1992 Ronai Z, Robinson R, Lee G, Okin E, Minarovits J, Wirchubsky Z, Klein G, Weinstein IB. Interaction of SEWA sarcoma cell proteins with the intracisternal A-type particle long terminal repeat DNA sequence. Molecular Carcinogenesis. 5: 81-9. PMID 1543543 DOI: 10.1002/Mc.2940050113  0.339
1992 Kuraya M, Yefenof E, Klein G, Klein E. Expression of the complement regulatory proteins CD21, CD55 and CD59 on Burkitt lymphoma lines: their role in sensitivity to human serum-mediated lysis. European Journal of Immunology. 22: 1871-6. PMID 1378022 DOI: 10.1002/Eji.1830220729  0.377
1992 Niedobitek G, Fahraeus R, Herbst H, Latza U, Ferszt A, Klein G, Stein H. The Epstein-Barr virus encoded membrane protein (LMP) induces phenotypic changes in epithelial cells. Virchows Archiv B Cell Pathology Including Molecular Pathology. 62: 55-59. PMID 1352076 DOI: 10.1007/Bf02899665  0.418
1992 Fåhraeus R, Chen W, Trivedi P, Klein G, Obrink B. Decreased expression of E-cadherin and increased invasive capacity in EBV-LMP-transfected human epithelial and murine adenocarcinoma cells. International Journal of Cancer. 52: 834-8. PMID 1330938 DOI: 10.1002/Ijc.2910520527  0.418
1992 Cuomo L, Ramquist T, Trivedi P, Wang F, Klein G, Masucci MG. Expression of the Epstein-Barr virus (EBV)-encoded membrane protein LMP1 impairs the in vitro growth, clonability and tumorigenicity of an EBV-negative Burkitt lymphoma line. International Journal of Cancer. 51: 949-55. PMID 1322379 DOI: 10.1002/Ijc.2910510619  0.439
1992 Gavioli R, De Campos-Lima PO, Kurilla MG, Kieff E, Klein G, Masucci MG. Recognition of the Epstein-Barr virus-encoded nuclear antigens EBNA-4 and EBNA-6 by HLA-A11-restricted cytotoxic T lymphocytes: implications for down-regulation of HLA-A11 in Burkitt lymphoma. Proceedings of the National Academy of Sciences of the United States of America. 89: 5862-6. PMID 1321426 DOI: 10.1073/Pnas.89.13.5862  0.359
1992 Altiok A, Bejarano MT, Klein G, Klein E. Effect of TGF‐β1 on the ebv‐induced transformation of human lymphocyte cultures International Journal of Cancer. 50: 772-776. PMID 1312065 DOI: 10.1002/Ijc.2910500518  0.303
1992 Wendel-Hansen V, Tao W, Ericson M, Klein G, Rosén A. Cell phenotype (CD23)-dependent variation in EBV genome copy numbers within lymphoblastoid cell lines (LCL). International Journal of Cancer. Journal International Du Cancer. 50: 589-92. PMID 1311286 DOI: 10.1002/Ijc.2910500417  0.362
1991 Zabarovsky ER, Boldog F, Thompson T, Scanlon D, Winberg G, Marcsek Z, Erlandsson R, Stanbridge EJ, Klein G, Sümegi J. Construction of a human chromosome 3 specific NotI linking library using a novel cloning procedure. Nucleic Acids Research. 18: 6319-24. PMID 2243778 DOI: 10.1093/Nar/18.21.6319  0.321
1991 Lewin N, Aman P, Akerlund B, Gustavsson E, Carenfelt C, Lejdeborn L, Klein G, Klein E. Epstein-Barr virus-carrying B cells in the blood during acute infectious mononucleosis give rise to lymphoblastoid lines in vitro by release of transforming virus and by proliferation. Immunology Letters. 26: 59-65. PMID 2177451 DOI: 10.1016/0165-2478(90)90176-Q  0.43
1991 Falk K, Ernberg I, Sakthivel R, Davis J, Christensson B, Luka J, Okano M, Grierson HL, Klein G, Purtilo DT. Expression of Epstein-Barr virus-encoded proteins and B-cell markers in fatal infectious mononucleosis. International Journal of Cancer. 46: 976-84. PMID 2174416 DOI: 10.1002/Ijc.2910460605  0.438
1991 Wiener F, Silva S, Sugiyama H, Babonits M, Klein G. The "missing" mouse plasmacytoma (MPC) associated translocation T(15;16) occurs repeatedly in new MPC induction systems. Genes, Chromosomes & Cancer. 2: 36-43. PMID 2126192 DOI: 10.1002/Gcc.2870020107  0.391
1991 Szabó G, Székely L, Schablik M, Klein G, Sümegi J, Szabó G. Inositol derivatives down-regulate c-myc inducing growth arrest without differentiation. Experimental Cell Research. 193: 420-4. PMID 2004655 DOI: 10.1016/0014-4827(91)90115-B  0.313
1991 Axelson H, Pear WS, Panda CK, Bazin H, Klein G, Sumegi J. Transcriptional deregulation of myc in IgH/myc 6;7 translocation carrying rat immunocytomas Genes Chromosomes and Cancer. 3: 142-148. PMID 1906344 DOI: 10.1002/Gcc.2870030210  0.302
1991 Andersson ML, Stam NJ, Klein G, Ploegh HL, Masucci MG. Aberrant expression of HLA class-I antigens in Burkitt lymphoma cells. International Journal of Cancer. 47: 544-50. PMID 1899854 DOI: 10.1002/Ijc.2910470412  0.384
1991 Silva S, Sugiyama H, Babonits M, Wiener F, Klein G. Differential susceptibility of BALB/c and DBA/2 cells to plasmacytoma induction in reciprocal chimeras. International Journal of Cancer. 49: 224-8. PMID 1879968 DOI: 10.1002/Ijc.2910490214  0.313
1991 Lewin N, Minarovits J, Weber G, Ehlin-Henriksson B, Wen T, Mellstedt H, Klein G, Klein E. Clonality and methylation status of the Epstein-Barr virus (EBV) genomes in in vivo-infected EBV-carrying chronic lymphocytic leukemia (CLL) cell lines. International Journal of Cancer. 48: 62-6. PMID 1850384 DOI: 10.1002/Ijc.2910480112  0.453
1991 Gratama JW, Zutter MM, Minarovits J, Oosterveer MA, Thomas ED, Klein G, Ernberg I. Expression of Epstein-Barr virus-encoded growth-transformation-associated proteins in lymphoproliferations of bone-marrow transplant recipients. International Journal of Cancer. Journal International Du Cancer. 47: 188-92. PMID 1846349 DOI: 10.1002/Ijc.2910470205  0.403
1991 Yamasaki T, Kikuchi H, Ljunggren HG, Kärre K, Klein G. [Cytotoxic effector mechanism and genetic control of non-immunized hybrid resistance to mouse T cell lymphoma transplanted outside and inside the brain]. Neurologia Medico-Chirurgica. 30: 800-5. PMID 1709455 DOI: 10.2176/Nmc.30.800  0.356
1991 Yamasaki T, Kikuchi H, Yamashita J, Ljunggren HG, Kärre K, Klein G. [Molecular analysis of relationship between oncogene (N-myc and c-src) expression and major histocompatibility complex antigen gene expression in mouse neuroblastoma lines]. Neurologia Medico-Chirurgica. 30: 789-95. PMID 1709453 DOI: 10.2176/Nmc.30.789  0.356
1991 Hu LF, Zabarovsky ER, Chen F, Cao SL, Ernberg I, Klein G, Winberg G. Isolation and sequencing of the Epstein-Barr virus BNLF-1 gene (LMP1) from a Chinese nasopharyngeal carcinoma. The Journal of General Virology. 2399-409. PMID 1681026 DOI: 10.1099/0022-1317-72-10-2399  0.348
1991 Klein G. Immunovirology of transforming viruses Current Opinion in Immunology. 3: 665-673. PMID 1661601 DOI: 10.1016/0952-7915(91)90094-H  0.369
1991 Ramqvist T, Norén L, Iwarsson K, Klein G. Tumorigenicity of EBV-carrying lymphoblastoid cell lines (LCLs): distinctive grading in SCID mice. International Journal of Cancer. 49: 587-591. PMID 1655664 DOI: 10.1002/Ijc.2910490420  0.337
1991 Minarovits J, Minarovits-Kormuta S, Ehlin-Henriksson B, Falk K, Klein G, Ernberg I. Host cell phenotype-dependent methylation patterns of Epstein-Barr virus DNA. The Journal of General Virology. 1591-9. PMID 1649897 DOI: 10.1099/0022-1317-72-7-1591  0.375
1991 Trivedi P, Masucci MG, Winberg G, Klein G. The epstein-Barr-virus-encoded membrane protein LMP but not the nuclear antigen EBNA-1 induces rejection of transfected murine mammary carcinoma cells. International Journal of Cancer. 48: 794-800. PMID 1649140 DOI: 10.1002/Ijc.2910480527  0.409
1991 Altiok A, Bejarano MT, Ruscetti F, Altiok E, Klein G, Klein E. Effect of Transforming Growth Factor-Beta 1 and -Beta 2 on the Proliferation of Burkitt Lymphoma and Lymphoblastoid Cell Lines Growth Factors Journal. 4: 117-128. PMID 1646619 DOI: 10.3109/08977199109000263  0.318
1990 Minarovits J, Steinitz M, Boldog F, Imreh S, Wirschubsky Z, Ingvarsson S, Hedenskog M, Minarovits-Kormuta S, Klein G. Differences in c-myc and pvt-1 amplification in SEWA sarcoma sublines selected for adherent or non-adherent growth. International Journal of Cancer. 45: 514-20. PMID 2307540 DOI: 10.1002/Ijc.2910450324  0.334
1990 Sugiyama H, Silva S, Wang YS, Weber G, Babonits M, Rosén A, Wiener F, Klein G. Abelson murine leukemia virus transforms preneoplastic Emu-myc transgene-carrying cells of the B-lymphocyte lineage into plasmablastic tumors. International Journal of Cancer. 46: 845-52. PMID 2228313 DOI: 10.1002/Ijc.2910460516  0.341
1990 Cuomo L, Trivedi P, Wang F, Winberg G, Klein G, Masucci MG. Expression of the Epstein-Barr virus (EBV)-encoded membrane antigen (LMP) increases the stimulatory capacity of EBV-negative B lymphoma lines in allogeneic mixed lymphocyte cultures. European Journal of Immunology. 20: 2293-9. PMID 2173662 DOI: 10.1002/Eji.1830201019  0.448
1990 Gratama JW, Oosterveer MA, Lepoutre JM, van Rood JJ, Zwaan FE, Vossen JM, Kapsenberg JG, Richel D, Klein G, Ernberg I. Serological and molecular studies of Epstein-Barr virus infection in allogeneic marrow graft recipients. Transplantation. 49: 725-30. PMID 2158159 DOI: 10.1097/00007890-199004000-00014  0.347
1990 Aman P, Rowe M, Kai C, Finke J, Rymo L, Klein E, Klein G. Effect of the EBNA-2 gene on the surface antigen phenotype of transfected EBV-negative B-lymphoma lines. International Journal of Cancer. 45: 77-82. PMID 2153641 DOI: 10.1002/Ijc.2910450115  0.38
1990 Wendel-Hansen V, Rivière M, Uno M, Jansson I, Szpirer J, Islam MQ, Levan G, Klein G, Yodoi J, Rosén A. The gene encoding CD23 leukocyte antigen (FCE2) is located on human chromosome 19. Somatic Cell and Molecular Genetics. 16: 283-6. PMID 2141728 DOI: 10.1007/Bf01233364  0.323
1990 Ohlén C, Bastin J, Ljunggren HG, Imreh S, Klein G, Townsend AR, Kärre K. Restoration of H-2b expression and processing of endogenous antigens in the MHC class I pathway by fusion of a lymphoma mutant to L cells of the H-2k haplotype. European Journal of Immunology. 20: 1873-6. PMID 2120065 DOI: 10.1002/Eji.1830200837  0.345
1990 Sugiyama H, Silva S, Babonits M, Potter M, Klein G, Wiener F. A murine plasmacytoma with a variant (15;16)(D2/3;B1) translocation that involves the c-myc and lambda light chain gene-carrying chromosomes. Cancer Genetics and Cytogenetics. 46: 93-7. PMID 2110029 DOI: 10.1016/0165-4608(90)90014-2  0.316
1990 Fhraeus R, Rymo L, Rhim JS, Klein G. Morphological transformation of human keratinocytes expressing the LMP gene of Epstein-Barr virus. Nature. 345: 447-449. PMID 1692971 DOI: 10.1038/345447A0  0.421
1990 Bejarano MT, Masucci MG, Morgan A, Morein B, Klein G, Klein E. Epstein-Barr virus (EBV) antigens processed and presented by B cells, B blasts, and macrophages trigger T-cell-mediated inhibition of EBV-induced B-cell transformation. Journal of Virology. 64: 1398-1401. DOI: 10.1128/Jvi.64.3.1398-1401.1990  0.307
1990 Altiok AO, Bejerano MT, Klein G, Klein E. The Effect of TGFβ on the Growth of Burkitt Lymphoma and Lymphoblastoid Cell Lines Annals of the New York Academy of Sciences. 593: 325-325. DOI: 10.1111/J.1749-6632.1990.Tb16133.X  0.349
1989 Erlandsson R, Boldog F, Sümegi J, Klein G. Do human renal cell carcinomas arise by a double-loss mechanism? Cancer Genetics and Cytogenetics. 36: 197-202. PMID 3203309 DOI: 10.1016/0165-4608(88)90145-8  0.303
1989 Ingvarsson S, Asker C, Axelson H, Klein G, Sümegi J. Structure and expression of B-myc, a new member of the myc gene family. Molecular and Cellular Biology. 8: 3168-74. PMID 2850482 DOI: 10.1128/Mcb.8.8.3168  0.325
1989 Uno M, Wirschubsky Z, Wiener F, Klein G. Relationship between tumorigenicity and the dosage of lymphoma- vs. normal-parent-derived chromosome 15 in somatic cell hybrids between lymphoma cells with rearranged pvt-1 gene and normal cells. International Journal of Cancer. 44: 353-9. PMID 2788146 DOI: 10.1002/Ijc.2910440228  0.372
1989 Yamasaki T, Ljunggren HG, Ohlén C, Klein G, Kärre K. Enhanced H-2 expression and T-cell-dependent rejection after intracerebral transplantation of the murine lymphoma YAC-1. Cellular Immunology. 120: 387-95. PMID 2785859 DOI: 10.1016/0008-8749(89)90206-2  0.341
1989 Silva S, Babonits M, Wiener F, Klein G. Plasmacytoma induction in radiochimeras. International Journal of Cancer. 44: 337-42. PMID 2759740 DOI: 10.1002/Ijc.2910440225  0.388
1989 Szabó G, Winberg G, Henriksson M, Klein G, Sümegi J. Efficient retroviral transfer of a mouse c-myc construct into HL60. Biochemical and Biophysical Research Communications. 163: 321-7. PMID 2673238 DOI: 10.1016/0006-291X(89)92138-4  0.341
1989 Sakthivel R, Christensson B, Ehlin-Henriksson B, Klein G. Immunophenotypic characterization of follicle-center-cell-derived non-Hodgkin's lymphomas. International Journal of Cancer. 43: 624-30. PMID 2649442 DOI: 10.1002/Ijc.2910430415  0.368
1989 Torsteinsdóttir S, Andersson ML, Avila-Cariño J, Ehlin-Henriksson B, Masucci MG, Klein G, Klein E. Reversion of tumorigenicity and decreased agarose clonability after EBV conversion of an IgH/myc translocation-carrying BL line. International Journal of Cancer. 43: 273-8. PMID 2645221 DOI: 10.1002/Ijc.2910430219  0.4
1989 Bauskin AR, Zion M, Szpirer J, Szpirer C, Islam MQ, Levan G, Klein G, Ben-Neriah Y. Expression and chromosomal assignment of a novel protein-tyrosine kinase gene related to the insulin receptor family. Haematology and Blood Transfusion. 32: 453-60. PMID 2625259 DOI: 10.1007/978-3-642-74621-5_79  0.327
1989 Kurakata S, Ramos OF, Klein G, Klein E. Lysis of P3HR-1 cells induced to enter the viral cycle by antibody-dependent and independent immunological mechanisms. Cellular Immunology. 123: 134-47. PMID 2550147 DOI: 10.1016/0008-8749(89)90274-8  0.445
1989 Sugiyama H, Weber G, Silva S, Babonits M, Wiener F, Klein G. The accelerating role of Abelson murine leukemia virus in murine plasmacytoma development: in vitro infection of spleen cells generates donor-type tumors after transfer to pristane-treated BALB/c mice. International Journal of Cancer. 44: 348-52. PMID 2547729 DOI: 10.1002/Ijc.2910440227  0.378
1989 Algarra I, Ohlén C, Perez M, Ljunggren HG, Klein G, Garrido F, Kärre K. NK sensitivity and lung clearance of MHC-class-I-deficient cells within a heterogeneous fibrosarcoma. International Journal of Cancer. 44: 675-80. PMID 2507453 DOI: 10.1002/Ijc.2910440420  0.359
1989 Saranath D, Panchal RG, Nair R, Mehta AR, Sanghavi V, Sumegi J, Klein G, Deo MG. Oncogene amplification in squamous cell carcinoma of the oral cavity Japanese Journal of Cancer Research. 80: 430-437. PMID 2502519 DOI: 10.1111/J.1349-7006.1989.Tb02332.X  0.309
1989 Klein G. Multiple phenotypic consequences of the Ig/Myc translocation in B-cell-derived tumors Genes Chromosomes and Cancer. 1: 3-8. PMID 2487145 DOI: 10.1002/Gcc.2870010103  0.367
1989 Szigeti R, Kallin B, Dillner J, Henle G, Henle W, Lerner RA, Rymo L, Timar L, Klein G. Epstein-Barr virus (EBV) antigen-specific leukocyte migration inhibition in infectious mononucleosis. II. Kinetics of sensitization against five EBV-encoded nuclear proteins and the latent membrane protein. Clinical Immunology and Immunopathology. 51: 396-405. PMID 2470542 DOI: 10.1016/0090-1229(89)90037-8  0.398
1989 Contreras-Salazar B, Klein G, Masucci MG. Host cell-dependent regulation of growth transformation-associated Epstein-Barr virus antigens in somatic cell hybrids. Journal of Virology. 63: 2768-2772. DOI: 10.1128/Jvi.63.6.2768-2772.1989  0.351
1988 Ingvarsson S, Asker C, Szpirer J, Levan G, Klein G. Rat c-raf oncogene is located on chromosome 4 and may be activated by sequences from chromosome 13. Somatic Cell and Molecular Genetics. 14: 401-5. PMID 3399964 DOI: 10.1007/Bf01534648  0.313
1988 Szabó G, Bunce C, Brown G, Klein G, Sümegi J. Independent variations of myc amplification, inducibility, maturation, and proliferation states in HL60. Experimental Cell Research. 175: 334-43. PMID 3282898 DOI: 10.1016/0014-4827(88)90197-8  0.341
1988 Aman P, Gordon J, Mellstedt H, Biberfeld P, Klein G. Buoyant density characterization of neoplastic cell populations in patients with chronic B-lymphocytic leukemia. European Journal of Haematology. 40: 142-8. PMID 3257927 DOI: 10.1111/J.1600-0609.1988.Tb00811.X  0.323
1988 Silva S, Babonits M, Wiener F, Klein G. Further studies on chromosome 15 trisomy in murine T-cell lymphomas: mapping of the relevant chromosome segment. International Journal of Cancer. 41: 738-43. PMID 3130314 DOI: 10.1002/Ijc.2910410517  0.341
1988 Yamasaki T, Klein G, Ljunggren HG, Höglund P, Ohlén C, Petersson MG, Kärre K. Effects of dimethyl sulfoxide treatment on H-2 expression and susceptibility to NK- or cytotoxic T-lymphocyte-mediated lysis of the YAC-1 lymphoma and its beta 2-microglobulin-deficient variant. Journal of the National Cancer Institute. 80: 263-9. PMID 3127594 DOI: 10.1093/Jnci/80.4.263  0.321
1988 Pear WS, Wahlstrom G, Nelson SF, Axelson H, Szeles A, Wiener F, Bazin H, Klein G, Sumegi J. 6;7 Chromosomal translocation in spontaneously arising rat immunocytomas: Evidence for c-myc breakpoint clustering and correlation between isotypic expression and the c-myc target Molecular and Cellular Biology. 8: 441-451. PMID 3122026 DOI: 10.1128/mcb.8.1.441-451.1988  0.314
1988 Klein G. Tumour suppressor genes Journal of Cell Science. 171-180. PMID 3077935 DOI: 10.1242/Jcs.1988.Supplement_10.13  0.342
1988 Avila-Carin̄o J, Torsteinsdottir S, Bejarano MT, Klein G, Klein E, Masucci MG. Combined treatment with interferon (IFN)-γ and tumor necrosis factor (TNF)-α up-regulates the expression of HLA class I determinants in Burkitt lymphoma lines Cellular Immunology. 117: 303-311. PMID 2848629 DOI: 10.1016/0008-8749(88)90120-7  0.388
1988 Sulitzeanu D, Szigeti R, Hatzubai A, Dillner J, Hammarskjöld M, Klein G, Klein E. Antibodies in human sera against the Epstein-Barr virus encoded latent membrane protein (LMP). Immunology Letters. 18: 301-306. PMID 2846438 DOI: 10.1016/0165-2478(88)90179-4  0.394
1988 Patel GV, Masucci MG, Winberg G, Klein G. Expression of the Epstein-Barr virus encoded EBNA-1 gene in stably transfected human and murine cell lines. International Journal of Cancer. 42: 592-8. PMID 2844682 DOI: 10.1002/Ijc.2910420421  0.431
1988 Lewin N, Aman P, Wennborg A, Ehlin-Henriksson B, Manneborg-Sandlund A, Klein E, Klein G. Surface marker characterization of EBV-carrying cells in blood of healthy seropositive individuals. Immunobiology. 177: 211-9. PMID 2844656 DOI: 10.1016/S0171-2985(88)80041-X  0.362
1988 Bejarano MT, Masucci MG, Klein G, Klein E. T-cell-mediated inhibition of EBV-induced B-cell transformation: recognition of virus particles. International Journal of Cancer. 42: 359-64. PMID 2843474 DOI: 10.1002/Ijc.2910420309  0.403
1988 Fahraeus R, Fu HL, Ernberg I, Finke J, Rowe M, Klein G, Falk K, Nilsson E, Yadav M, Busson P, Tursz T, Kallin B. Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma International Journal of Cancer. 42: 329-338. PMID 2843473 DOI: 10.1002/Ijc.2910420305  0.396
1988 Hatzubai A, Lerner RA, Klein G, Sulitzeanu D. Proteins in normal and malignant cells, cross-reacting with the latent membrane protein encoded by Epstein-Barr virus. European Journal of Immunology. 18: 1283-8. PMID 2843380 DOI: 10.1002/Eji.1830180820  0.391
1988 Rowe M, Finke J, Szigeti R, Klein G. Characterization of the serological response in man to the latent membrane protein and the six nuclear antigens encoded by Epstein-Barr virus. The Journal of General Virology. 1217-28. PMID 2838572 DOI: 10.1099/0022-1317-69-6-1217  0.313
1988 Lewin N, Aman P, Mellstedt H, Zech L, Klein G. Direct outgrowth of in vivo Epstein-Barr virus (EBV)-infected chronic lymphocytic leukemia (CLL) cells into permanent lines International Journal of Cancer. 41: 892-895. PMID 2836321 DOI: 10.1002/Ijc.2910410621  0.447
1988 Torsteinsdottir S, Brautbar C, Klein G, Klein E, Masucci MG. Differential expression of hla antigen of HLA anigens on human B‐cell lines of normal and malignant origin: A consequence of immune surveillance or a phenotypic vestige of the progenitor cells? International Journal of Cancer. 41: 913-919. PMID 2453477 DOI: 10.1002/Ijc.2910410625  0.335
1987 Wendel-Hansen V, Rosén A, Klein G. EBV-transformed lymphoblastoid cell lines down-regulate EBNA in parallel with secretory differentiation. International Journal of Cancer. 39: 404-8. PMID 3546163 DOI: 10.1002/Ijc.2910390322  0.436
1987 Szabó G, Damjanovich S, Sümegi J, Klein G. Overall changes in chromatin sensitivity to DNase I during differentiation. Experimental Cell Research. 169: 158-68. PMID 3469102 DOI: 10.1016/0014-4827(87)90234-5  0.359
1987 Klein G. The approaching era of the tumor suppressor genes Science. 238: 1539-1545. PMID 3317834 DOI: 10.1126/Science.3317834  0.349
1987 Welinder C, Larsson NG, Szigeti R, Ehlin-Henriksson B, Henle G, Henle W, Klein G, Ricksten A, Rymo L, Sulitzeanu D. Stable transfection of a human lymphoma line by sub-genomic fragments of Epstein-Barr virus DNA to measure humoral and cellular immunity to the corresponding proteins. International Journal of Cancer. Journal International Du Cancer. 40: 389-95. PMID 3040603 DOI: 10.1002/Ijc.2910400318  0.462
1987 Wennborg A, Aman P, Saranath D, Pear W, Sümegi J, Klein G. Conversion of the lymphoma line "BJAB" by Epstein-Barr virus into phenotypically altered sublines is accompanied by increased c-myc mRNA levels. International Journal of Cancer. 40: 202-6. PMID 3038758 DOI: 10.1002/Ijc.2910400213  0.374
1987 Bejarano MT, Thorsteinsdottir S, Andersson JP, Andersson UG, Masucci MG, Szigeti R, Klein E, Klein G. Defective cell-mediated response to EBV-transformed B cells in a healthy individual with regular EBV antibody titers. International Journal of Cancer. 40: 149-56. PMID 3038755 DOI: 10.1002/Ijc.2910400204  0.411
1987 Masucci G, Mellstedt H, Masucci MG, Ernberg I, Szigeti R, Henle G, Henle W, Klein G. Analysis of Epstein-Barr virus-specific and non-specific immune functions in a patient during the development of a non-Hodgkin's lymphoma. European Journal of Cancer & Clinical Oncology. 23: 379-86. PMID 3038561 DOI: 10.1016/0277-5379(87)90373-7  0.414
1987 Ramqvist T, Reinholdsson G, Szigeti R, Klein G, Dalianis T. Studies on the polyoma tumor-specific transplantation antigen (TSTA): selection and characterization of TSTA-negative segregants from somatic hybrids. International Journal of Cancer. 40: 74-80. PMID 3036722 DOI: 10.1002/Ijc.2910400114  0.395
1987 Lewin N, Aman P, Masucci MG, Klein E, Klein G, Oberg B, Strander H, Henle W, Henle G. Characterization of EBV-carrying B-cell populations in healthy seropositive individuals with regard to density, release of transforming virus and spontaneous outgrowth. International Journal of Cancer. Journal International Du Cancer. 39: 472-6. PMID 3030940 DOI: 10.1002/Ijc.2910390411  0.416
1987 Otsu M, Katamine S, Uno M, Yamaki M, Ono Y, Klein G, Sasaki MS, Yaoita Y, Honjo T. Molecular characterization of novel reciprocal translocation t(6;14) in an Epstein-Barr virus-transformed B cell precursor. Molecular and Cellular Biology. 7: 708-17. PMID 3029565 DOI: 10.1128/Mcb.7.2.708  0.413
1987 Ehlin-Henriksson B, Manneborg-Sandlund A, Klein G. Expression of B-cell-specific markers in different Burkitt lymphoma subgroups. International Journal of Cancer. 39: 211-8. PMID 3026973 DOI: 10.1002/Ijc.2910390215  0.39
1987 Henle W, Henle G, Andersson J, Ernberg I, Klein G, Horwitz CA, Marklund G, Rymo L, Wellinder C, Straus SE. Antibody responses to Epstein-Barr virus-determined nuclear antigen (EBNA)-1 and EBNA-2 in acute and chronic Epstein-Barr virus infection. Proceedings of the National Academy of Sciences of the United States of America. 84: 570-4. PMID 3025881 DOI: 10.1073/Pnas.84.2.570  0.373
1987 Finke J, Rowe M, Kallin B, Ernberg I, Rosén A, Dillner J, Klein G. Monoclonal and polyclonal antibodies against Epstein-Barr virus nuclear antigen 5 (EBNA-5) detect multiple protein species in Burkitt's lymphoma and lymphoblastoid cell lines. Journal of Virology. 61: 3870-8. PMID 2824821 DOI: 10.1128/Jvi.61.12.3870-3878.1987  0.461
1987 Avila-Cariño J, Torsteinsdottir S, Ehlin-Henriksson B, Lenoir G, Klein G, Klein E, Masucci MG. Paired Epstein-Barr virus (EBV)-negative and EBV-converted Burkitt lymphoma lines: stimulatory capacity in allogeneic mixed lymphocyte cultures. International Journal of Cancer. 40: 691-7. PMID 2824386 DOI: 10.1002/Ijc.2910400521  0.324
1987 Classon M, Henriksson M, Sumegi J, Klein G, Hammaskjöld ML. Elevated c-myc expression facilitates the replication of SV40 DNA in human lymphoma cells Nature. 330: 272-274. PMID 2823151 DOI: 10.1038/330272A0  0.396
1987 Uno M, Wirschubsky Z, Babonits M, Wiener F, Sümegi J, Klein G. The role of chromosome 15 in murine leukemogenesis. II. Relationship between tumorigenicity and the dosage of lymphoma vs. normal-parent-derived chromosomes 15 in somatic cell hybrids. International Journal of Cancer. 40: 540-9. PMID 2822584 DOI: 10.1002/Ijc.2910400418  0.376
1987 Dillner J, Szigeti R, Henle W, Henle G, Lerner RA, Klein G. Cellular and humoral immune responses to synthetic peptides deduced from the amino-acid sequences of Epstein-Barr virus-encoded proteins in EBV-transformed cells. International Journal of Cancer. Journal International Du Cancer. 40: 455-60. PMID 2444542 DOI: 10.1002/Ijc.2910400404  0.345
1987 Dillner J, Rabin H, Letvin N, Henle W, Henle G, Klein G. Nuclear DNA-binding proteins determined by the Epstein-Barr virus-related simian lymphotropic herpesviruses H. gorilla, H. pan, H. pongo and H. papio. The Journal of General Virology. 68: 1587-96. PMID 2438377 DOI: 10.1099/0022-1317-68-6-1587  0.347
1986 Manolov G, Manolova Y, Klein G, Lenoir G, Levan A. Alternative involvement of two cytogenetically distinguishable breakpoints on chromosome 8 in Burkitt's lymphoma associated translocations. Cancer Genetics and Cytogenetics. 20: 95-9. PMID 3943061 DOI: 10.1016/0165-4608(86)90111-1  0.327
1986 Szigeti R, Rabin H, Timar L, Klein G. Leukocyte migration inhibition detects cross-reacting antigens between cells transformed by Epstein-Barr virus (EBV) and EBV-like simian viruses. Intervirology. 26: 121-8. PMID 3034820 DOI: 10.1159/000149691  0.434
1986 Aman P, Lewin N, Nordström M, Klein G. EBV-activation of human B-lymphocytes. Current Topics in Microbiology and Immunology. 132: 266-71. PMID 3024919 DOI: 10.1007/978-3-642-71562-4_40  0.352
1986 Szigeti R, Timar L, Weiland O, Henle W, Henle G, Hennessy K, Kieff E, Sulitzeanu D, Dillner J, Klein G. Epstein-Barr virus (EBV) antigen-specific leukocyte migration inhibition (LMI) in infectious mononucleosis (IM). I. Kinetics and response to a membrane protein on EBV-transformed cells. Clinical Immunology and Immunopathology. 41: 342-50. PMID 3022972 DOI: 10.1016/0090-1229(86)90005-X  0.416
1986 Wirschubsky Z, Tsichlis P, Klein G, Sumegi J. Rearrangement of c-myc, pim-1 and Mlvi-1 and trisomy of chromosome 15 in MCF- and Moloney-MuLV-induced murine T-cell leukemias. International Journal of Cancer. 38: 739-45. PMID 3021636 DOI: 10.1002/Ijc.2910380518  0.393
1986 Ernberg I, Kallin B, Dillner J, Falk K, Ehlin-Henriksson B, Hammarskjöld ML, Klein G. Lymphoblastoid cell lines and Burkitt-lymphoma-derived cell lines differ in the expression of a second Epstein-Barr virus encoded nuclear antigen. International Journal of Cancer. 38: 729-37. PMID 3021635 DOI: 10.1002/Ijc.2910380517  0.437
1986 Pear WS, Ingvarsson S, Steffen D, Münke M, Francke U, Bazin H, Klein G, Sümegi J. Multiple chromosomal rearrangements in a spontaneously arising t(6;7) rat immunocytoma juxtapose c-myc and immunoglobulin heavy chain sequences. Proceedings of the National Academy of Sciences of the United States of America. 83: 7376-80. PMID 3020544 DOI: 10.1073/Pnas.83.19.7376  0.33
1986 Ernberg I, Björkholm M, Zech L, Sandstedt B, Szigeti R, Andersson J, Henle W, Klein G. An EBV genome carrying pre-B cell leukemia in a homosexual man with characteristic karyotype and impaired EBV-specific immunity. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 4: 1481-8. PMID 3020182 DOI: 10.1200/Jco.1986.4.10.1481  0.45
1986 Hammarskjöld ML, Wang SC, Klein G. High-level expression of the Epstein-Barr virus EBNA1 protein in CV1 cells and human lymphoid cells using a SV40 late replacement vector. Gene. 43: 41-50. PMID 3019836 DOI: 10.1016/0378-1119(86)90006-5  0.435
1986 Torsteinsdottir S, Masucci MG, Brautbar C, Lenoir G, Klein G, Klein E. Differential recognition of tumor-derived and in vitro Epstein-Barr virus-transformed B-cell lines by fetal calf serum-specific T4-positive cytotoxic T-lymphocyte clones. Cellular Immunology. 98: 453-66. PMID 3019570 DOI: 10.1016/0008-8749(86)90304-7  0.427
1986 Wang SC, Hammarskjöld ML, Klein G. Immunoprecipitation of Epstein-Barr virus EBNA1 protein using human polyclonal serum. Journal of Virological Methods. 13: 323-32. PMID 3018021 DOI: 10.1016/0166-0934(86)90057-1  0.384
1986 Torsteinsdottir S, Masucci MG, Ehlin-Henriksson B, Brautbar C, Ben Bassat H, Klein G, Klein E. Differentiation-dependent sensitivity of human B-cell-derived lines to major histocompatibility complex-restricted T-cell cytotoxicity. Proceedings of the National Academy of Sciences of the United States of America. 83: 5620-4. PMID 3016710 DOI: 10.1073/Pnas.83.15.5620  0.317
1986 Hu CP, Aman P, Masucci MG, Klein E, Klein G. B cell activation by the nontransforming P3HR-1 substrain of the Epstein-Barr virus (EBV). European Journal of Immunology. 16: 841-5. PMID 3013647 DOI: 10.1002/Eji.1830160720  0.425
1986 Sulitzeanu D, Szigeti R, Klein G, Hennessy K, Kieff E. Leukocyte migration inhibition demonstrates a human T-cell response to a membrane protein expressed in latent Epstein-Barr virus infection Journal of Virology. 58: 230-232. PMID 3005653 DOI: 10.1128/Jvi.58.1.230-232.1986  0.387
1986 Dillner J, Kallin B, Ehlin-Henriksson B, Rymo L, Henle W, Henle G, Klein G. The Epstein-Barr virus determined nuclear antigen is composed of at least three different antigens. International Journal of Cancer. Journal International Du Cancer. 37: 195-200. PMID 2417963 DOI: 10.1002/Ijc.2910370205  0.393
1985 Klein G, Klein E. Myc/Ig juxtaposition by chromosomal translocations: some new insights, puzzles and paradoxes Immunology Today. 6: 208-215. PMID 25290182 DOI: 10.1016/0167-5699(85)90036-2  0.372
1985 Gazitt Y, Ehlin-Henriksson B, Lerner A, Klein G. Subgroup analysis of BL-cell lines with polyclonal BL-specific antibodies. International Journal of Cancer. 34: 839-43. PMID 6439652 DOI: 10.1002/Ijc.2910340615  0.394
1985 Wirschubsky Z, Ingvarsson S, Carstenssen A, Wiener F, Klein G, Sumegi J. Gene localization on sorted chromosomes: Definitive evidence on the relative positioning of genes participating in the mouse plasmacytoma-associated typical translocation Proceedings of the National Academy of Sciences of the United States of America. 82: 6975-6979. PMID 2995997 DOI: 10.1073/Pnas.82.20.6975  0.307
1985 Rymo L, Klein G, Ricksten A. Expression of a second Epstein-Barr virus-determined nuclear antigen in mouse cells after gene transfer with a cloned fragment of the viral genome. Proceedings of the National Academy of Sciences of the United States of America. 82: 3435-9. PMID 2987926 DOI: 10.1073/Pnas.82.10.3435  0.431
1985 Szigeti R, Masucci MG, Masucci G, Aman P, Klein G, Klein E. Leukocyte migration inhibitory factor production by activated lymphocytes representing immunological memory or virus-receptor interaction: response of T cell subsets to Epstein-Barr virus nuclear antigen, response of B cells to UV inactivated Epstein-Barr virus. Immunology Letters. 9: 267-73. PMID 2987111 DOI: 10.1016/0165-2478(85)90006-9  0.408
1985 Dillner J, Kallin B, Ehlin-Henriksson B, Timar L, Klein G. Characterization of a second Epstein-Barr virus-determined nuclear antigen associated with the BamHI WYH region of EBV DNA. International Journal of Cancer. 35: 359-66. PMID 2982749 DOI: 10.1002/Ijc.2910350312  0.441
1985 Bejarano MT, Masucci MG, Ernberg I, Klein E, Klein G. Effect of cyclosporin-A (CsA) on the ability of T lymphocyte subsets to inhibit the proliferation of autologous EBV-transformed B cells. International Journal of Cancer. 35: 327-33. PMID 2982748 DOI: 10.1002/Ijc.2910350308  0.369
1985 Gordon J, Åman P, Rosén A, Ernberg I, Ehlin-Henriksson B, Klein G. Capacity of B-lymphocytic lines of diverse tumor origin to produce and respond to B-cell growth factors: a progression model for B-cell lymphomagenesis. International Journal of Cancer. 35: 251-256. PMID 2982745 DOI: 10.1002/Ijc.2910350218  0.398
1985 Torsteinsdottir S, Masucci MG, Bejarano MT, Berthold W, Klein E, Klein G. Selective inhibitory effect of Hu-IFN-gamma on the agarose clonability of tumor-derived lymphoid cell lines. Cellular Immunology. 90: 65-73. PMID 2981638 DOI: 10.1016/0008-8749(85)90169-8  0.37
1985 Banerjee M, Wiener F, Spira J, Babonits M, Nilsson M, Sumegi J, Klein G. Mapping of the c-myc, pvt-1 and immunoglobulin kappa genes in relation to the mouse plasmacytoma-associated variant (6;15) translocation breakpoint. The Embo Journal. 4: 3183-3188. DOI: 10.1002/J.1460-2075.1985.Tb04063.X  0.316
1985 Dillner J, Kallin B, Klein G, Jörnvall H, Alexander H, Lerner R. Antibodies against synthetic peptides react with the second Epstein-Barr virus-associated nuclear antigen. The Embo Journal. 4: 1813-1818. DOI: 10.1002/J.1460-2075.1985.Tb03855.X  0.378
1984 Vánky F, Péterffy A, Böök K, Willems J, Klein E, Klein G. Correlation between lymphocyte-mediated auto-tumor reactivities and the clinical course. II. Evaluation of 69 patients with lung carcinoma. Cancer Immunology, Immunotherapy : Cii. 16: 17-22. PMID 6605800 DOI: 10.1007/Bf00199900  0.324
1984 Klein G, Klein E. Torbjörn Caspersson: some personal perspectives. Cytometry. 5: 318. PMID 6380993 DOI: 10.1002/Cyto.990050405  0.322
1984 Klein G, Klein E. Oncogene activation and tumor progression. Carcinogenesis. 5: 429-35. PMID 6368033 DOI: 10.1093/Carcin/5.4.429  0.314
1984 Somssich IE, Spira J, Hameister H, Klein G. Correlation between tumorigenicity and banding pattern of chromosome 15 in murine T-cell leukemia cells and hybrids of normal and malignant cells. Chromosoma. 91: 39-45. PMID 6335425 DOI: 10.1007/Bf00286483  0.368
1984 Szigeti R, Sulitzeanu D, Henle G, Henle W, Klein G. Detection of an Epstein-Barr virus-associated membrane antigen in Epstein-Barr virus-transformed nonproducer cells by leukocyte migration inhibition and blocking antibody. Proceedings of the National Academy of Sciences of the United States of America. 81: 4178-82. PMID 6330746 DOI: 10.1073/Pnas.81.13.4178  0.421
1984 Torsteinsdottir S, Masucci MG, Lenoir G, Klein G, Klein E. Natural killer cell sensitivity of human lymphoid lines of B-cell origin does not correlate with tumorigenicity or with the expression of certain differentiation markers. Cellular Immunology. 86: 278-86. PMID 6329520 DOI: 10.1016/0008-8749(84)90382-4  0.324
1984 Wirschubsky Z, Wiener F, Spira J, Sümegi J, Klein G. Triplication of one chromosome No. 15 with an altered c-myc containing EcoRI fragment and elimination of the normal homologue in a T-cell lymphoma line of AKR origin (TIKAUT). International Journal of Cancer. 33: 477-81. PMID 6323325 DOI: 10.1002/Ijc.2910330410  0.381
1984 Wells A, Koide N, Eggertsen G, Lundwall A, Godal T, Steen HB, Klein G. Epstein-Barr virus binding to virus-carrying cell lines is enhanced in the presence of C3 and C3d. The Journal of General Virology. 507-13. PMID 6321638 DOI: 10.1099/0022-1317-65-3-507  0.534
1984 Szigeti R, Masucci G, Ehlin-Henriksson B, Bendtzen K, Henle G, Henle W, Klein G, Klein E. EGNA-specific LIF production of human lymphocyte subsets. Cellular Immunology. 83: 136-41. PMID 6319032 DOI: 10.1016/0008-8749(84)90232-6  0.332
1984 Geser A, Lenoir GM, Anvret M, Bornkamm G, Klein G, Williams EH, Wright DH, De-The G. Epstein-Barr virus markers in a series of Burkitt's lymphomas from the West Nile District, Uganda. European Journal of Cancer & Clinical Oncology. 19: 1393-404. PMID 6315443 DOI: 10.1016/0277-5379(93)90009-T  0.345
1984 Ehlin-Henriksson B, Klein G. Distinction between Burkitt lymphoma subgroups by monoclonal antibodies: relationships between antigen expression and type of chromosomal translocation. International Journal of Cancer. 33: 459-63. PMID 6231253 DOI: 10.1002/Ijc.2910330407  0.381
1984 Merino F, Grönberg A, Klein G. T-cell-dependent hybrid resistance against a natural killer-resistant Moloney virus-induced lymphoma (YWA): in vitro generation of cytotoxic lymphocytes. Cellular Immunology. 83: 313-20. PMID 6229343 DOI: 10.1016/0008-8749(84)90310-1  0.414
1984 Dillner J, Sternås L, Kallin B, Alexander H, Ehlin-Henriksson B, Jörnvall H, Klein G, Lerner R. Antibodies against a synthetic peptide identify the Epstein-Barr virus-determined nuclear antigen. Proceedings of the National Academy of Sciences of the United States of America. 81: 4652-6. PMID 6205400 DOI: 10.1073/Pnas.81.15.4652  0.349
1984 Svedmyr E, Ernberg I, Seeley J, Weiland O, Masucci G, Tsukuda K, Szigeti R, Masucci MG, Blomgren H, Berthold W, Henle W, Klein G. Virologic, immunologic, and clinical observations on a patient during the incubation, acute, and convalescent phases of infectious mononucleosis Clinical Immunology and Immunopathology. 30: 437-450. PMID 6199144 DOI: 10.1016/0090-1229(84)90029-1  0.403
1984 Gergely L, Luka J, Klein G. Interaction between Epstein-Barr virus-determined nuclear antigen (EBNA) and the viral DNA. The Journal of General Virology. 2043-8. PMID 6094716 DOI: 10.1099/0022-1317-65-11-2043  0.348
1984 Gergely L, Sternås L, Dillner J, Klein G. Molecular Size Variation of EBNA is Determined by the EB Viral Genome Intervirology. 22: 85-96. PMID 6090339 DOI: 10.1159/000149538  0.405
1984 Dalianis T, Ramqvist T, Klein G. Studies on the polyoma-virus-induced tumor-specific transplantation antigen (TSTA)--does middle or large T-antigen play a role? International Journal of Cancer. 34: 403-6. PMID 6090322 DOI: 10.1002/Ijc.2910340318  0.378
1984 Wirschubsky Z, Wiener F, Bregula U, Klein G. Further studies on the asymmetry of chromosome 15 duplication in trisomic leukemias of heterozygous origin: preferential status of the AKR chromosome. International Journal of Cancer. 34: 249-54. PMID 6088404 DOI: 10.1002/Ijc.2910340217  0.312
1983 Patarroyo M, Yogeeswaran G, Biberfeld P, Klein E, Klein G. Morphological changes, cell aggregation and cell membrane alterations caused by phorbol 12,13-dibutyrate in human blood lymphocytes. International Journal of Cancer. 30: 707-17. PMID 6962179 DOI: 10.1002/Ijc.2910300606  0.345
1983 Wiener F, Spira J, Babonits M, Klein G. Non-random duplication of chromosome 15 in T-cell leukemias induced in mice heterozygous for reciprocal and Robertsonian translocations. International Journal of Cancer. 30: 479-87. PMID 6815106 DOI: 10.1002/Ijc.2910300415  0.325
1983 Sümegi J, Spira J, Bazin H, Szpirer J, Levan G, Klein G. Rat c-myc oncogene is located on chromosome 7 and rearranges in immunocytomas with t(6:7) chromosomal translocation Nature. 306: 497-498. PMID 6646229 DOI: 10.1038/306497A0  0.314
1983 Das HR, Codington JF, Lampert LA, Maxfield MD, Jeanloz RW, Miller SC, Klein G, Dalianis T. Studies on the possible chemical, immunochemical and morphological differences at the cell surfaces of immunosensitive and immunoresistant, moloney virus-induced, lymphoma cell-lines Carbohydrate Research. 120: 303-314. PMID 6627250 DOI: 10.1016/0008-6215(83)88024-0  0.396
1983 Gordon J, Aman P, Mellstedt H, Biberfeld P, Klein G. In vitro differentiation of chronic lymphocytic leukaemia cells with a small pre-B-like phenotype. Leukemia Research. 7: 133-8. PMID 6602252 DOI: 10.1016/0145-2126(83)90003-6  0.336
1983 Asjö B, Klein E, Fenyö EM, Klein G. The role of humoral immunity and the contribution of the F1 anti-parental effect in the rejection of a Moloney leukemia virus-induced lymphoma graft. Cancer Immunology, Immunotherapy : Cii. 15: 92-5. PMID 6553518 DOI: 10.1007/Bf00199697  0.333
1983 Rosén A, Klein G. UV light-induced immunoglobulin heavy-chain class switch in a human lymphoblastoid cell line Nature. 306: 189-190. PMID 6417540 DOI: 10.1038/306189A0  0.39
1983 Grönberg A, Kiessling R, Masucci G, Guevara LA, Eriksson E, Klein G. Gamma-interferon (IFN-gamma) produced during effector and target interactions renders target cells less susceptible to NK-cell-mediated lysis. International Journal of Cancer. 32: 609-16. PMID 6417032 DOI: 10.1002/Ijc.2910320515  0.36
1983 Grönberg A, Cochran AJ, Kärre K, Klein G, Klein GO, Kiessling R. Incidence and type of tumors induced by DMBA carcinogenesis in H‐2 congenic strains on a B10 background International Journal of Cancer. 32: 247-252. PMID 6409817 DOI: 10.1002/Ijc.2910320217  0.307
1983 Spira J, Wiener F, Klein G. Robertsonian translocation studies on the significance of trisomy 15 in murine T-cell leukemia. Cancer Genetics and Cytogenetics. 9: 45-9. PMID 6404548 DOI: 10.1016/0165-4608(83)90023-7  0.342
1983 Patarroyo M, Biberfeld P, Klein E, Klein G. Phorbol 12,13-dibutyrate (P(Bu)2)-treated human blood mononuclear cells bind to each other. Cellular Immunology. 75: 144-53. PMID 6402310 DOI: 10.1016/0008-8749(83)90313-1  0.346
1983 Klein G. Specific chromosomal translocations and the genesis of B-cell-derived tumors in mice and men Cell. 32: 311-315. PMID 6402307 DOI: 10.1016/0092-8674(83)90449-X  0.354
1983 Sternås L, Luka J, Kallin B, Rosén A, Henle W, Henle G, Klein G. Enzyme-linked immunosorbent assay for the detection of Epstein-Barr virus-induced antigens and antibodies. Journal of Immunological Methods. 63: 171-85. PMID 6311908 DOI: 10.1016/0022-1759(83)90422-2  0.387
1983 Ringborg U, Henle W, Henle G, Ingimarsson S, Klein G, Silfversward C, Strander H. Epstein-Barr virus-specific serodiagnostic tests in carcinomas of the head and neck. Cancer. 52: 1237-43. PMID 6309355 DOI: 10.1002/1097-0142(19831001)52:7<1237::Aid-Cncr2820520718>3.0.Co;2-P  0.344
1983 Saemundsen AK, Perlmann C, Klein G. Intracellular Epstein-Barr virus DNA is methylated in and around the EcoRI-J fragment in both producer and nonproducer cell lines. Virology. 126: 701-6. PMID 6305009 DOI: 10.1016/S0042-6822(83)80026-9  0.383
1983 Klein G, Manneborg-Sandlund A, Ehlin-Henriksson B, Godal T, Wiels J, Tursz T. Expression of the BLA antigen, defined by the monoclonal 38.13 antibody, on Burkitt lymphoma lines, lymphoblastoid cell lines, their hybrids and other B-cell lymphomas and leukemias. International Journal of Cancer. 31: 535-42. PMID 6303966 DOI: 10.1002/Ijc.2910310503  0.427
1983 Patarroyo M, Klein E, Klein G. Lymphocyte-mediated lysis of autologous and allogeneic B-cell lines in man. Immunology Letters. 6: 101-5. PMID 6303952 DOI: 10.1016/0165-2478(83)90089-5  0.392
1983 Wells A, Koide N, Stein H, Gerdes J, Klein G. The Epstein-Barr virus receptor is distinct from the C3 receptor. The Journal of General Virology. 449-53. PMID 6300295 DOI: 10.1099/0022-1317-64-2-449  0.528
1983 Johnson DR, Wolfe LG, Levan G, Klein G, Ernberg I, Aman P. Epstein-Barr virus (EBV)-induced lymphoproliferative disease in cotton-topped marmosets. International Journal of Cancer. 31: 91-7. PMID 6299974 DOI: 10.1002/Ijc.2910310115  0.399
1983 Luka J, Sternas L, Jornvall H, Klein G, Lerner R. Antibodies of predetermined specificity for the NH2 terminus of a cellular protein p53 react with the native molecule: evidence for the presence of different p53s. Proceedings of the National Academy of Sciences of the United States of America. 80: 1199-1203. PMID 6298784 DOI: 10.1073/Pnas.80.5.1199  0.338
1983 Kallin B, Klein G. Epstein-Barr virus carried by Raji cells: a mutant in early functions? Intervirology. 19: 47-51. PMID 6298144 DOI: 10.1159/000149336  0.389
1983 Perlmann C, Saemundsen AK, Klein G. A fraction of Epstein--Barr virus virion DNA is methylated in and around the EcoRI-J fragment. Virology. 123: 217-21. PMID 6293192 DOI: 10.1016/0042-6822(82)90308-7  0.33
1983 Anisimová E, Saemundsen AK, Roubal J, Vonka V, Klein G. Effects of n-butyrate on Epstein-Barr virus-carrying lymphoma lines. The Journal of General Virology. 163-71. PMID 6292341 DOI: 10.1099/0022-1317-58-1-163  0.433
1983 Argov S, Cantell K, Klein E, Klein G. Immune interferon (IFN-γ) production in autologous mixed cultures Cellular Immunology. 76: 196-199. PMID 6219753 DOI: 10.1016/0008-8749(83)90361-1  0.302
1983 Gordon J, Mellstedt H, Aman P, Biberfeld P, Bjorkholm M, Klein G. Phenotypes in chronic B-lymphocytic leukemia probed by monoclonal antibodies and immunoglobulin secretion studies: identification of stages of maturation arrest and the relation to clinical findings Blood. 62: 910-917. DOI: 10.1182/Blood.V62.4.910.910  0.341
1983 Klein G. Significance of Specific Chromosomal Translocations and Trisomies for the Genesis of Murine and Human Tumors of the Lymphocyte-Plasmacyte Lineage Progress in Nucleic Acid Research and Molecular Biology. 29: 35-38. DOI: 10.1016/S0079-6603(08)60427-4  0.345
1982 Spira J, Wiener F, Babonits M, Gamble J, Miller J, Klein G. The role of chromosome 15 in murine leukemogenesis. I. Contrasting behavior of the tumor vs. normal parent-derived chromosomes No. 15 in somatic hybrids of varying tumorigenicity. International Journal of Cancer. 28: 785-98. PMID 7333707 DOI: 10.1002/Ijc.2910280618  0.338
1982 Povey S, Jeremiah S, Arthur E, Steel M, Klein G. Differences in genetic stability between human cell lines from patients with and without lymphoreticular malignancy. Annals of Human Genetics. 44: 119-33. PMID 7316467 DOI: 10.1111/J.1469-1809.1980.Tb00953.X  0.355
1982 Asjö B, Fenyö EM, Klein G. Moloney virus (M-MuLV) leukemogenesis: virus spread, antibody production and antigenic expression in neonatally virus-inoculated young mice. International Journal of Cancer. 28: 65-70. PMID 7309282 DOI: 10.1002/Ijc.2910280112  0.332
1982 Grönberg A, Klein GO, Kärre K, Kiessling R, Klein G. Hybrid resistance against a natural killer (NK) cell-resistant lymphoma (YWA) is mediated by a T cell-dependent mechanism European Journal of Cancer and Clinical Oncology. 18: 183-190. PMID 7201394 DOI: 10.1016/0277-5379(82)90062-1  0.359
1982 Zhang S, Wu Y, Zeng Y, Zech L, Klein G. Cytogenetic studies on an epithelioid cell line derived from nasopharyngeal carcinoma Hereditas. 97: 23-28. PMID 7129938 DOI: 10.1111/J.1601-5223.1982.Tb00706.X  0.374
1982 Steinitz M, Koide N, Spira G, Tamir S, Klein G. In vitro produced monoclonal rheumatoid factor: purification, radiolabel, and possible applications. Cellular Immunology. 69: 205-14. PMID 7105186 DOI: 10.1016/0008-8749(82)90067-3  0.356
1982 Asjö B, Skoog L, Fenyö EM, Klein G. Different T-cell subtypes are associated with pathologically distinct forms of Moloney leukemia virus (M-MuLV)-induced lymphoma. International Journal of Cancer. 29: 163-7. PMID 7037658 DOI: 10.1002/Ijc.2910290209  0.376
1982 Klein GO, Kárre K, Kiessling R, Klein G. Thymus independence of hybrid resistance against a panel of T-cell lymphomas of H-2b origin International Journal of Cancer. 30: 659-662. PMID 6984022 DOI: 10.1002/Ijc.2910300518  0.318
1982 Jörnvall H, Luka J, Klein G, Appella E. A 53-kilodalton protein common to chemically and virally transformed cells shows extensive sequence similarities between species. Proceedings of the National Academy of Sciences of the United States of America. 79: 287-91. PMID 6952184 DOI: 10.1073/Pnas.79.2.287  0.359
1982 Wu Y, Ernberg I, Masucci MG, Johnson D, Klein E, Klein G. Human T cell growth factor (TCGF) produced by repeated stimulation of non-adherent human lymphocytes. Journal of Immunological Methods. 51: 35-44. PMID 6809829 DOI: 10.1016/0022-1759(82)90379-9  0.332
1982 Klein GO, Grönberg A, Kiessling R, Klein G. Decreased sensitivity of immunoselected and NK-selected YAC lymphoma sublines to hybrid resistance in vivo. European Journal of Cancer and Clinical Oncology. 18: 191-198. PMID 6807680 DOI: 10.1016/0277-5379(82)90063-3  0.347
1982 Klein G, Lenoir G. Translocations Involving Ig-Locus-Carrying Chromosomes: A Model For Genetic Transposition in Carcinogenesis Advances in Cancer Research. 37: 381-387. PMID 6305162 DOI: 10.1016/S0065-230X(08)60887-8  0.378
1982 Nilsson K, Klein G. Phenotypic and cytogenetic characteristics of human B-lymphoid cell lines and their relevance for the etiology of Burkitt's lymphoma. Advances in Cancer Research. 37: 319-380. PMID 6305160 DOI: 10.1016/S0065-230X(08)60886-6  0.444
1982 Saemundsen AK, Albeck H, Hansen JP, Nielsen NH, Anvret M, Henle W, Henle G, Thomsen KA, Kristensen HK, Klein G. Epstein-Barr virus in nasopharyngeal and salivary gland carcinomas of Greenland Eskimoes. British Journal of Cancer. 46: 721-8. PMID 6293523 DOI: 10.1038/Bjc.1982.264  0.345
1982 Wells A, Godal T, Kvaløy S, Steen HB, Klein G. Quantitative comparison of Epstein-Barr virus receptor expression on sIgM and sIgG cell lines and B-cell lymphoma biopsies. Differentiation; Research in Biological Diversity. 22: 113-9. PMID 6290303 DOI: 10.1111/J.1432-0436.1982.Tb01234.X  0.528
1982 Szigeti R, Dalianis T, Klein G, Ito Y, Magnusson G. Detection of polyoma-virus-induced tumor antigen(s) by macrophage migration inhibition. International Journal of Cancer. 30: 69-74. PMID 6288580 DOI: 10.1002/Ijc.2910300113  0.393
1982 Sternås L, Luka J, Kallin B, Vestergaard BF, Klein G. Detection and characterization of EBV antigens by micro-ELISA and chromatofocusing. Journal of Virological Methods. 4: 229-40. PMID 6286703 DOI: 10.1016/0166-0934(82)90069-6  0.355
1982 Tsukuda K, Tsukuda Y, Klein G. Suppressor T cells activated by autologous B-cell derived lines inhibit blastogenic responses by peripheral lymphocytes to mitogens or autologous lymphoblastoid cell lines. Cellular Immunology. 69: 291-304. PMID 6286150 DOI: 10.1016/0008-8749(82)90074-0  0.395
1982 Shapiro IM, Volsky DJ, Saemundsen AK, Anisimova E, Klein G. Infection of the human T-cell-derived leukemia line Molt-4 by Epstein-Barr virus (EBV): induction of EBV-determined antigens and virus reproduction. Virology. 120: 171-81. PMID 6285596 DOI: 10.1016/0042-6822(82)90015-0  0.427
1982 Purtilo DT, Sakamoto K, Barnabei V, Seeley J, Bechtold T, Rogers G, Yetz J, Harada S, Berkel I, Brooks C, Bucchanan G, Collins R, Cruzi F, Finkelstein G, Glomstein A, ... ... Klein G, et al. Epstein-Barr virus-induced diseases in boys with the X-linked lymphoproliferative syndrome (XLP). Update on studies of the registry The American Journal of Medicine. 73: 49-56. PMID 6283885 DOI: 10.1016/0002-9343(82)90923-8  0.334
1982 Koide N, Wells A, Klein G, Ernberg I. Cell surface glycoprotein patterns of two EBV-negative lines and their EBV converted sublines. Intervirology. 16: 142-8. PMID 6277822 DOI: 10.1159/000149261  0.512
1982 Tsukuda K, Volsky DJ, Shapiro IM, Klein G. Epstein-Barr virus (EBV) receptor implantation onto human B lymphocytes changes immunoglobulin secretion patterns induced by EBV infection. European Journal of Immunology. 12: 87-90. PMID 6277643 DOI: 10.1002/Eji.1830120116  0.385
1982 Manolov G, Manolova Y, Klein G, Levan A, Kieler J. Chromosome #14 markers in two Epstein-Barr virus (EBV)-transformed lymphoblastoid cell lines of normal origin differ from the Burkitt lymphoma (BL)-associated 14q+ marker. Cancer Genetics and Cytogenetics. 4: 179-84. PMID 6277469 DOI: 10.1016/0165-4608(81)90082-0  0.374
1982 McCormick KH, Giovanella BC, Klein G, Nilsson K, Stehlin JS. Diploid human lymphoblastoid and Burkitt lymphoma cell lines: susceptibility to murine NK cells and heterotransplantation to nude mice. International Journal of Cancer. 28: 455-8. PMID 6273332 DOI: 10.1002/Ijc.2910280410  0.416
1982 Wells A, Steen H, Saeland S, Godal T, Klein G. A microassay for quantitatively detecting the Epstein-Barr virus receptor on single cells utilizing flow cytometry. Journal of Virological Methods. 3: 127-36. PMID 6271799 DOI: 10.1016/0166-0934(81)90047-1  0.529
1982 Somssich IE, Spira J, Hameister H, Klein G. Cytogenetic replication studies on murine T-cell leukemias with special consideration to chromosome 15 Chromosoma. 86: 197-208. PMID 6183060 DOI: 10.1007/Bf00288676  0.355
1982 Sternås L, Kallin B, Luka J, Klein G. Immunochemical characterization of EBV antigens detected by double immunodiffusion. Intervirology. 17: 208-14. PMID 6182123 DOI: 10.1159/000149290  0.302
1982 Patarroyo M, Klein E, Klein G. The increased natural killer sensitivity of Epstein-Barr virus (EBV)-superinfected Raji cells is not due to the recognition of serologically determined EBV antigens by the effectors. Cellular Immunology. 67: 152-9. PMID 6176334 DOI: 10.1016/0008-8749(82)90207-6  0.405
1982 Ben-Sasson SA, Klein G. Activation of the Epstein-Barr virus genome by 5-aza-cytidine in latently infected human lymphoid lines. International Journal of Cancer. 28: 131-5. PMID 6172387 DOI: 10.1002/Ijc.2910280204  0.404
1982 Dalianis T, Magnusson G, Ito Y, Klein G. Immunization against the polyoma virus-induced tumor-specific transplantation antigen by early region mutants of the virus. Journal of Virology. 43: 772-777. DOI: 10.1128/Jvi.43.3.772-777.1982  0.372
1982 Klein G, Zeuthen J, Ber R, Ernberg I. Human Lymphoma-Lymphoma Hybrids and Lymphoma-Leukemia Hybrids. II. Epstein-Barr Virus Induction Patterns Journal of the National Cancer Institute. 68: 197-202. DOI: 10.1093/Jnci/68.2.197  0.438
1982 Zeuthen J, Klein G, Ber R, Masucci G, Bisballe S, Povey S, Terasaki P, Ralph P. Human Lymphoma-Lymphoma Hybrids and Lymphoma-Leukemia Hybrids. I. Isolation, Characterization, Cell Surface Markers, and B-Cell Markers Journal of the National Cancer Institute. 68: 179-195. DOI: 10.1093/Jnci/68.2.179  0.43
1981 Wiener F, Babonits M, Spira J, Klein G, Potter M. Cytogenetic studies on IgA/lambda-producing murine plasmacytomas: regular occurrence of a T(12;15) translocation. Somatic Cell Genetics. 6: 731-8. PMID 7444720 DOI: 10.1007/Bf01538972  0.342
1981 Klein G. The role of gene dosage and genetic transpositions in carcinogenesis Nature. 294: 313-318. PMID 7312030 DOI: 10.1038/294313A0  0.346
1981 Asjö B, Buetti E, Fenyö EM, Diggelmann H, Klein G. Moloney murine leukemia virus variants with distinct p30 peptide maps are associated with different clinical types of leukemia. European Journal of Cancer. 17: 187-92. PMID 7262156 DOI: 10.1016/0014-2964(81)90035-9  0.313
1981 Dalianis T, Ährlund-Richter L, Merino F, Klein E, Klein G. Reduced humoral and cellular cytotoxic sensitivity in histocompatibility variants of the YAC (Moloney) lymphoma. Immunogenetics. 12: 371-380. PMID 7203561 DOI: 10.1007/Bf01561677  0.361
1981 Spira J, Asjö B, Cochran A, Shen FW, Wiener F, Klein G. Chromosomal, histopathological and cell surface marker studies on Moloney virus induced lymphomas. Leukemia Research. 5: 113-21. PMID 7017292 DOI: 10.1016/0145-2126(81)90069-2  0.435
1981 Volsky DJ, Ahrlund-Richter L, Dalianis T, Klein G. Implantation of mouse histocompatibility antigens into membranes of cultured tumor cells. European Journal of Immunology. 11: 341-4. PMID 6972874 DOI: 10.1002/Eji.1830110415  0.354
1981 McConnell I, Klein G, Macanovic M, Gorman NT, Raniwalla J. Malignant cells isolated from Burkitt's lymphoma but not other forms of leukemia activate the alternative complement pathway in human serum. European Journal of Immunology. 11: 132-5. PMID 6938374 DOI: 10.1002/Eji.1830110213  0.339
1981 Klein GO, Klein G. Genetic differences in F1 hybrid resistance against tumours of the same parental strain. I. Tumours of C57Bl/6 origin European Journal of Cancer and Clinical Oncology. 17: 731-742. PMID 6800800 DOI: 10.1016/0014-2964(81)90228-0  0.305
1981 Johnson DR, Ohno S, Kaschka-Dierich C, Fleckenstein B, Klein G. Relationship between Herpesvirus ateles-associated nuclear antigen (HATNA) and the number of virus genome equivalents in HVA-carrying lymphoid lines. The Journal of General Virology. 52: 221-6. PMID 6793691 DOI: 10.1099/0022-1317-52-2-221  0.404
1981 Tsukuda K, Tsukuda Y, Klein G. Suppressor T cells activated by lymphoblastoid cell lines inhibit pokeweed mitogen-induced immunoglobulin synthesis. Cellular Immunology. 60: 191-202. PMID 6453655 DOI: 10.1016/0008-8749(81)90259-8  0.417
1981 Rymo L, Lindahl T, Povey S, Klein G. Analysis of restriction endonuclease fragments of intracellular Epstein-Barr virus DNA and isoenzymes indicate a common origin of the Raji, NC-37, and F-265 human lymphoid cell lines. Virology. 115: 115-24. PMID 6270894 DOI: 10.1016/0042-6822(81)90093-3  0.387
1981 Koide N, Wells A, Volsky DJ, Shapiro IM, Klein G. The detection of Epstein-Barr virus receptors utilizing radiolabelled virus. The Journal of General Virology. 54: 191-5. PMID 6270245 DOI: 10.1099/0022-1317-54-1-191  0.544
1981 Wells A, Koide N, Klein G. Difference in viral binding between two Epstein-Barr virus substrains to a spectrum of receptor-positive target cells. International Journal of Cancer. 27: 303-9. PMID 6270014 DOI: 10.1002/Ijc.2910270308  0.553
1981 Patarroyo M, Blazar B, Pearson G, Klein E, Klein G. Induction of the EBV cycle in B-lymphocyte-derived lines is accompanied by increased natural killer (NK) sensitivity and the expression of EBV-related antigen(s) detected by the ADCC reaction. International Journal of Cancer. 26: 365-71. PMID 6270007 DOI: 10.1002/Ijc.2910260317  0.402
1981 Volsky DJ, Klein G, Volsky B, Shapiro IM. Production of infectious Epstein--Barr virus in mouse lymphocytes. Nature. 293: 399-401. PMID 6268991 DOI: 10.1038/293399A0  0.409
1981 Roubal J, Klein G. Synthesis of thymidine kinase (TK) in Epstein-Barr virus-superinfected Raji TK-negative cells. Intervirology. 15: 43-8. PMID 6268568 DOI: 10.1159/000149213  0.4
1981 Patarroyo M, Biberfeld P, Klein E, Klein G. 12-O- tetradecanoylphorbol- 13 acetate (TPA) treatment elevates the natural killer (NK) sensitivity of certain human lymphoid lines. Cellular Immunology. 63: 237-48. PMID 6268309 DOI: 10.1016/0008-8749(81)90003-4  0.41
1981 Johnson DR, Levan G, Klein G, Nigida SM, Wolfe LG. Chromosomes and cell surface markers of marmoset lymphocytes and Epstein-Barr virus-transformed marmoset cell lines. Cancer Genetics and Cytogenetics. 3: 101-8. PMID 6268289 DOI: 10.1016/0165-4608(81)90064-9  0.422
1981 Shapiro IM, Klein G, Volsky DJ. Epstein-Barr virus co-reconstituted with Sendai virus envelopes infects Epstein-Barr virus-receptor negative cells. Biochimica Et Biophysica Acta. 676: 19-24. PMID 6266500 DOI: 10.1016/0304-4165(81)90004-0  0.428
1981 Staczek J, Steplewski Z, Weinmann R, Klein G, Koprowski H. Epstein-Barr virus in nontumorigenic and tumorigenic nasopharyngeal carcinoma (NPC) somatic cell hybrids. Journal of Cellular Physiology. 107: 391-8. PMID 6265479 DOI: 10.1002/Jcp.1041070311  0.425
1981 Johnson DR, Ernberg I, Klein G. Interaction of herpesvirus ateles with marmoset lymphocytes. II. Identification of target cell population and stimulation of DNA synthesis after infection in vitro. Intervirology. 14: 202-7. PMID 6263823 DOI: 10.1159/000149183  0.343
1981 Roubal J, Luka J, Klein G. Effect of retinoic acid (RA) on the Epstein-Barr virus (EBV)-inducing effect of sodium butyrate. Cancer Letters. 8: 209-12. PMID 6261939 DOI: 10.1016/0304-3835(80)90003-8  0.335
1981 Lau RY, Nonoyama M, Klein G. Somatic cell hybrids between human lymphoma and human myeloid leukemia cells. I. Induction of resident viral genome transcription and viral antigen formation by IUDR and TPA. Virology. 110: 259-69. PMID 6261446 DOI: 10.1016/0042-6822(81)90058-1  0.43
1981 Szigeti R, Luka J, Klein G. Leukocyte migration inhibition studies with Epstein-Barr virus (EBV) determined nuclear antigen (EBNA) in relation to the EBV-carrier status of the donor. Cellular Immunology. 58: 269-76. PMID 6260386 DOI: 10.1016/0008-8749(81)90220-3  0.409
1981 Saemundsen AK, Berkel AI, Henle W, Henle G, Anvret M, Sanal O, Ersoy F, Ca?lar M, Klein G. Epstein-Barr-virus-carrying lymphoma in a patient with ataxia-telangiectasia. British Medical Journal (Clinical Research Ed.). 282: 425-7. PMID 6257325 DOI: 10.1136/Bmj.282.6262.425  0.364
1981 Panet A, Falk H, Fenyö EM, Klein G. Restriction of murine leukemia proviral gene expression in somatic mouse cell hybrids. Virology. 106: 197-206. PMID 6254247 DOI: 10.1016/0042-6822(80)90244-5  0.407
1981 Kuzumaki N, Hilgers J, Klein G. Serological definition of individually distinct surface antigens in mouse mammary carcinomas. European Journal of Cancer. 16: 1569-81. PMID 6164557 DOI: 10.1016/0014-2964(80)90030-4  0.392
1981 Åman P, Lundin G, Hall K, Klein G. Insulin receptors on human lymphoid lines of B-cell origin Cellular Immunology. 65: 307-316. DOI: 10.1016/0008-8749(81)90076-9  0.302
1980 Asjö B, Fenyö EM, Spira J, Klein G. Appearance and distribution of virally determined antigens in lymphoid organs of mice during leukemogenesis by Moloney leukemia virus. Leukemia Research. 4: 89-103. PMID 7412358 DOI: 10.1016/0145-2126(80)90049-1  0.42
1980 Kärre K, Klein GO, Kiessling R, Klein G, Roder JC. Low natural in vivo resistance to syngeneic leukaemias in natural killer-deficient mice. Nature. 284: 624-6. PMID 7366734 DOI: 10.1038/284624A0  0.332
1980 Kärre K, Klein GO, Kiessling R, Klein G, Roder JC. In vitro NK-activity and in vivo resistance to leukemia: studies of beige, beige//nude and wild-type hosts on C57BL background. International Journal of Cancer. Journal International Du Cancer. 26: 789-97. PMID 7216547 DOI: 10.1002/Ijc.2910260613  0.346
1980 Galili U, Klein E, Klein G, Biberfeld P. The natural attachment of thymocytes and activated T lymphocytes to normal and malignant cells: an interspecies study. Developmental and Comparative Immunology. 4: 367-73. PMID 6772486 DOI: 10.1016/S0145-305X(80)80039-5  0.324
1980 Klein G. Immune and non-immune control of neoplastic development: Contrasting effects of host and tumor evolution Cancer. 45: 2486-2498. PMID 6769579 DOI: 10.1002/1097-0142(19800515)45:10<2486::Aid-Cncr2820451005>3.0.Co;2-#  0.342
1980 Johnson DR, Klein G, Falk L. Interaction of Herpesvirus Ateles and Herpesvirus Saimiri with Primate Lymphocytes Intervirology. 13: 21-27. PMID 6766914 DOI: 10.1159/000149102  0.319
1980 Karande A, Fialkow PJ, Nilsson K, Povey S, Klein G, Najfeld V, Penfold G. Establishment of a lymphoid cell line from leukemic cells of a patient with chronic lymphocytic leukemia International Journal of Cancer. 26: 551-556. PMID 6263808 DOI: 10.1002/Ijc.2910260505  0.306
1980 Saemundsen AK, Kallin B, Klein G. Effect of n-butyrate on cellular and viral DNA synthesis in cells latently infected with Epstein-Barr virus. Virology. 107: 557-61. PMID 6256952 DOI: 10.1016/0042-6822(80)90326-8  0.371
1980 Volsky DJ, Shapiro IM, Klein G. Transfer of Epstein-Barr virus receptors to receptor-negative cells permits virus penetration and antigen expression. Proceedings of the National Academy of Sciences of the United States of America. 77: 5453-7. PMID 6254082 DOI: 10.1073/Pnas.77.9.5453  0.404
1980 Klein G, Luka J, Zeuthen J. Transformation Induced by Epstein-Barr Virus and the Role of the Nuclear Antigen Cold Spring Harbor Symposia On Quantitative Biology. 44: 253-261. PMID 6253139 DOI: 10.1101/Sqb.1980.044.01.029  0.345
1980 Galili U, Klein E, Klein G, Singh Bal I. Activated T lymphocytes in infiltrates and draining lymph nodes of nasopharyngeal carcinoma. International Journal of Cancer. 25: 85-9. PMID 6249765 DOI: 10.1002/Ijc.2910250111  0.35
1980 Jønsson VU, Klein G, Christensen BE. Changed Fc and C3 receptor pattern on human EBV-negative lymphoma cells, following in vitro conversion by EB-virus. European Journal of Cancer. 16: 533-8. PMID 6249610 DOI: 10.1016/0014-2964(80)90233-9  0.352
1980 Kuzumaki N, Hilgers J, Moerkerk P, Ber R, Asjö B, Wiener F, Klein G. Restriction of C-type viral antigen in H-2/Fv-1 syngeneic mouse somatic cell hybrids. Intervirology. 13: 201-8. PMID 6248481 DOI: 10.1159/000149127  0.378
1980 Moar MH, Klein G. Effect of mitomycin C and hydroxyurea on the expression of the Epstein-Barr virus cycle following P3HR-1 superinfection. Intervirology. 13: 178-85. PMID 6246034 DOI: 10.1159/000149123  0.392
1980 Fenyö EM, Klein G, Povey S, Jeremiah SJ, Spira J, Wiener F, Harris H. Suppression and reappearance of N-tropic L virus production in somatic cell hybrids after introduction and loss of chromosomes carrying Fv-1b. European Journal of Cancer. 16: 357-68. PMID 6245889 DOI: 10.1016/0014-2964(80)90353-9  0.403
1980 Schulz T, Dierich MP, Yefenof E, Klein G. C3-activating proteases on human lymphoblastoid cells superinfected with Epstein-Barr Virus. Cellular Immunology. 51: 168-72. PMID 6244899 DOI: 10.1016/0008-8749(80)90246-4  0.383
1980 Ragona G, Ernberg I, Klein G. Induction and biological characterization of the Epstein-Barr virus (EBV) carried by the Jijoye lymphoma line. Virology. 101: 553-7. PMID 6244705 DOI: 10.1016/0042-6822(80)90473-0  0.415
1980 Blazar B, Patarroyo M, Klein E, Klein G. Increased sensitivity of human lymphoid lines to natural killer cells after induction of the Epstein-Barr viral cycle by superinfection or sodium butyrate. The Journal of Experimental Medicine. 151: 614-27. PMID 6244358 DOI: 10.1084/Jem.151.3.614  0.311
1980 Klein G, Vilcek J. Attempts to induce interferon production by IdUrd induction and EBV superinfection in human lymphoma lines and their hybrids. The Journal of General Virology. 46: 111-7. PMID 6243338 DOI: 10.1099/0022-1317-46-1-111  0.427
1980 Masucci MG, Szigeti R, Klein E, Klein G, Gruest J, Montagnier L, Taira H, Hall A, Nagata S, Weissmann C. Effect of interferon-alpha 1 from E. coli on some cell functions. Science (New York, N.Y.). 209: 1431-5. PMID 6158096 DOI: 10.1126/Science.6158096  0.38
1980 Polliack A, Yefenof E, Gamliel H, Klein G. Burkitt's lymphoma cells: membrane properties and surface morphology as seen by scanning electron microscopy. Leukemia Research. 3: 217-25. PMID 230393 DOI: 10.1016/0145-2126(79)90045-6  0.33
1980 Kuzumaki N, Ber R, More IA, Cochran AJ, Weiner F, Klein G. Viral expression and immunogenicity of CBA mammary carcinomas and their hybrid lines with an L-cell derivative (A9HT). European Journal of Cancer. 15: 1253-61. PMID 230057 DOI: 10.1016/0014-2964(79)90251-2  0.422
1980 Dölken G, Moar MH, Klein G. Detection of the Epstein-Barr virus-associated antigens EA (early antigen) and VCA (viral capsid antigen) by direct or indirect binding of iodinated antibodies to antigen immobilized in polyacrylamide gel. European Journal of Cancer. 15: 821-4. PMID 228942 DOI: 10.1016/0014-2964(79)90159-2  0.343
1980 Luka J, Jörnvall H, Klein G. Purification and biochemical characterization of the Epstein-Barr virus-determined nuclear antigen and an associated protein with a 53,000-dalton subunit. Journal of Virology. 35: 592-602. DOI: 10.1128/Jvi.35.3.592-602.1980  0.331
1980 Klein G, Zeuthen J, Eriksson I, Terasaki P, Bernoco M, Rosén A, Masucci G, Povey S, Ber R. Hybridization of a Myeloid Leukemia-Derived Human Cell Line (K562) With a Human Burkitt's Lymphoma Line (P3HR-1) Journal of the National Cancer Institute. 64: 725-738. DOI: 10.1093/Jnci/64.4.725  0.442
1979 Hellström U, Hammarström S, Klein G. Enrichment of Helix pomatia (HP) lectin binding variant from the TA3St mouse ascites tumor by repeated column selection. European Journal of Cancer. 14: 1265-72. PMID 738331 DOI: 10.1016/0014-2964(78)90234-7  0.371
1979 Andersson LC, Jokinen M, Gahmberg CG, Klein E, Klein G, Nilsson K. Presence of erythrocytic components in the K562 cell line. International Journal of Cancer. 24: 514-514. PMID 528075 DOI: 10.1002/Ijc.2910240422  0.302
1979 Ohno S, Babonits M, Wiener F, Spira J, Klein G, Potter M. Nonrandom chromosome changes involving the Ig gene-carrying chromosomes 12 and 6 in pristane-induced mouse plasmacytomas. Cell. 18: 1001-1007. PMID 519762 DOI: 10.1016/0092-8674(79)90212-5  0.359
1979 Klein G, Klein E. Induction of tumor cell rejection in the low responsive YAC-lymphoma strain A host combination by immunization with somatic cell hybrids. European Journal of Cancer. 15: 551-7. PMID 436915 DOI: 10.1016/0014-2964(79)90092-6  0.433
1979 Shapiro IM, Luka J, Andersson-Anvret M, Klein G. Relationship between Epstein-Barr virus genome number, amount of nuclear antigen, and early antigen inducibility in diploid tetraploid lymphoma cells of related origin Intervirology. 12: 19-25. PMID 227812 DOI: 10.1159/000149064  0.409
1979 Giovanella B, Nilsson K, Zech L, Yim O, Klein G, Stehlin JS. Growth of diploid, Epstein-Barr virus-carrying human lymphoblastoid cell lines heterotransplanted into nude mice under immunologically privileged conditions International Journal of Cancer. 24: 103-113. PMID 225282 DOI: 10.1002/Ijc.2910240118  0.375
1979 Andersson-Anvret M, Forsby N, Klein G, Henle W, Biörklund A. Relationship between the Epstein-Barr virus genome and nasopharyngeal carcinoma in Caucasian patients. International Journal of Cancer. Journal International Du Cancer. 23: 762-7. PMID 223991 DOI: 10.1002/Ijc.2910230605  0.35
1979 Klein G. Expression of differentiated functions in hybrid cells Differentiation. 13: 61-62. PMID 223931 DOI: 10.1111/J.1432-0436.1979.Tb01622.X  0.315
1979 Svedmyr E, Klein G, Weiland O. The EBV-carrying, β2M/HLA deficient Burkitt lymphoma line Daudi is sensitive to EBV-specific killer T-cells of mononucleosis patients Cancer Letters. 7: 15-20. PMID 222436 DOI: 10.1016/S0304-3835(79)80071-3  0.38
1979 Klein G. Lymphoma development in mice and humans: diversity of initiation is followed by convergent cytogenetic evolution. Proceedings of the National Academy of Sciences of the United States of America. 76: 2442-2446. PMID 221925 DOI: 10.1073/Pnas.76.5.2442  0.42
1979 Luka J, Kallin B, Klein G. Induction of the Epstein-Barr virus (EBV) cycle in latently infected cells by n-butyrate. Virology. 94: 228-31. PMID 220786 DOI: 10.1016/0042-6822(79)90455-0  0.432
1979 van Beek WP, Nilsson K, Klein G, Emmelot P. Cell surface glycoprotein changes in Epstein-Barr virus-positive and -negative human hematopoietic cell lines. International Journal of Cancer. Journal International Du Cancer. 23: 464-73. PMID 220199 DOI: 10.1002/Ijc.2910230405  0.452
1979 Steinitz M, Klein G. Superinfection of EBV-carrying lines with herpes virus papio (HVP): induction of early antigen (EA) and inhibition of cellular DNA synthesis. European Journal of Cancer. 15: 217-22. PMID 220052 DOI: 10.1016/0014-2964(79)90063-X  0.439
1979 Klein G, Manneborg A, Steinitz M. Differences in EBV receptor concentration between in vitro EBV-converted lymphoma sublines reflect biological differences between the converting viral substrains. International Journal of Cancer. 23: 197-200. PMID 216641 DOI: 10.1002/Ijc.2910230210  0.37
1979 Klein G, Hyman R, Trowbridge I. Correlated expression of a B-lymphocyte-specific glycoprotein (gp27/35) and the EBV receptor/C3 receptor complex in sublines from the same Burkitt lymphoma. International Journal of Cancer. 23: 37-41. PMID 215562 DOI: 10.1002/Ijc.2910230108  0.341
1979 Viallat J, Svedmyr E, Yefenof E, Klein G, Weiland O. Stimulation of human peripheral blood lymphocytes by autologous EBV-infected B cells. Cellular Immunology. 41: 1-8. PMID 214248 DOI: 10.1016/S0008-8749(78)80023-9  0.391
1979 Steplewski Z, Koprowski H, Andersson-Anvret M, Klein G. Epstein-Barr virus in somatic cell hybrids between mouse cells and human nasopharyngeal carcinoma cells. Journal of Cellular Physiology. 97: 1-8. PMID 213442 DOI: 10.1002/Jcp.1040970102  0.425
1979 Falk L, Lindahl T, Bjursell G, Klein G. Herpesvirus papio: state and properties of intracellular viral DNA in baboon lymphoblastoid cell lines. International Journal of Cancer. 24: 75-9. PMID 113352 DOI: 10.1002/Ijc.2910240113  0.376
1979 Wiener F, Spira J, Ohno S, Haran-Ghera N, Klein G. Non-random duplication of chromosome 15 in murine T-cell leukemias induced in mice heterozygous for translocation T(14:15)6. International Journal of Cancer. 23: 504-7. PMID 108228 DOI: 10.1002/Ijc.2910230410  0.338
1979 Moar MH, Klein G. Abortive expression of the epstein‐barr virus (EBV) cycle in a variety of EBV DNA‐containing cell lines, as reflected by nucleic acid hybridization In situ International Journal of Cancer. 24: 679-687. PMID 93584 DOI: 10.1002/Ijc.2910240524  0.421
1979 Pearson GR, Qualtiere LF, Klein G, Norin T, Bal IS. Epstein-Barr virus-specific antibody-dependent cellular cytotoxicity in patients with Burkitt's lymphoma International Journal of Cancer. 24: 402-406. PMID 93578 DOI: 10.1002/Ijc.2910240405  0.372
1979 Klein G, Ehlin B, Witz I. Serological detection of a polyoma-tumor-associated membrane antigen. International Journal of Cancer. 23: 683-90. PMID 88422 DOI: 10.1002/Ijc.2910230515  0.356
1979 Ohno S, Luka J, Klein G. Evidence for antigenic distinctness of the Epstein--Barr virus-determined nuclear antigen and the Herpesvirus papio-determined nuclear antigen. Cancer Letters. 6: 325-329. PMID 88257 DOI: 10.1016/S0304-3835(79)80089-0  0.341
1979 Karande A, Yefenof E, Fenyo EM, Klein G. Moloney lymphoma cells express a polyprotein containing the gag gene-coded p15 and the Moloney leukemia virus-induced cell surface antigen (MCSA) International Journal of Cancer. 23: 508-513. PMID 86525 DOI: 10.1002/Ijc.2910230411  0.331
1979 Kuzumaki N, Klein G. Serologically defined, unique surface antigen on a mouse mammary adenocarcinoma. Journal of the National Cancer Institute. 62: 619-22. PMID 84092 DOI: 10.1093/Jnci/62.3.619  0.416
1979 Moar MH, Ber R, Klein G, Westman A, Eriksson I. Somatic cell hybrids between human lymphoma cell lines. V. IdUrd inducibility and P3HR-1 superinfectability of Daudi/HeLa (DAD) and Daudi/P3HR-1 (DIP-1) cell lines. International Journal of Cancer. 22: 669-74. PMID 82545 DOI: 10.1002/Ijc.2910220605  0.344
1979 Dalianis T, Klein G, Andersson B. Selection of a Low Antigenic Variant Subline From the TA3St Ascites Carcinoma by Repeated Passage of Antibody-Coated Cells Through Anti-immunoglobulin Columns Journal of the National Cancer Institute. 63: 383-388. DOI: 10.1093/Jnci/63.2.383  0.37
1979 Andersson LC, Jokinen M, Gahmberg CG, Klein E, Klein G, Nilsson K. Effects of sodium butyrate on human chronic myelogenous leukaemia cell line K562 (reply) Nature. 281: 710-710. DOI: 10.1038/281710A0  0.305
1979 Steinitz M, Seppälä I, Eichmann K, Klein G. Establishment of A Human Lymphoblastoid Cell Line with Specific Antibody Production Against Group A Streptococcal Carbohydrate Zeitschrift FüR ImmunitäTsforschung: Immunobiology. 156: 41-47. DOI: 10.1016/S0340-904X(79)80060-3  0.367
1979 Dalianis T, Klein G, Andersson B. Column selection of antigenic variants from tumors. Yac (moloney) lymphoma variants with reduced antigen expression. Immunogenetics. 9: 465-475. DOI: 10.1007/Bf01570439  0.373
1978 Kuzumaki N, Fenyö EM, Klein E, Klein G. Protective effect of murine sarcoma virus-superinfected mouse tumor cells against outgrowth of corresponding noninfected tumor. Transplantation. 26: 304-307. PMID 705875 DOI: 10.1097/00007890-197811000-00008  0.416
1978 Codington JF, Klein G, Cooper AG, Lee N, Brown MC, Jeanloz RW. Further studies on the relationship between large glycoprotein molecules and allotransplantability in the TA3 tumor of the mouse: studies on segregating TA3-Ha hybrids Journal of the National Cancer Institute. 60: 811-818. PMID 633390 DOI: 10.1093/Jnci/60.4.811  0.372
1978 Yefenof E, Bakacs T, Einhorn L, Ernberg I, Klein G. Epstein-Barr virus (EBV) receptors, complement receptors, and EBV infectibility of different lymphocyte fractions of human peripheral blood. I. Complement receptor distribution and complement binding by separated lymphocyte subpopulations Cellular Immunology. 35: 34-42. PMID 340053 DOI: 10.1016/0008-8749(78)90124-7  0.348
1978 Wiener F, Ohno S, Spira J, Haran-Ghera N, Klein G. Cytogenetic mapping of the trisomic segment of chromosome 15 in murine T-cell leukaemia. Nature. 275: 658-60. PMID 309097 DOI: 10.1038/275658A0  0.327
1978 Ohno S, Luka J, Falk LA, Klein G. Serological reactivities of human and baboon sera against EBNA and Herpesvirus papio-determined nuclear antigen (HUPNA). European Journal of Cancer. 14: 955-960. PMID 213288 DOI: 10.1016/0014-2964(78)90022-1  0.354
1978 Steinitz M, Bakács T, Klein G. Interaction of the B95-8 and P3HR-1 substrains of Epstein-Barr virus (EBV) with peripheral human lymphocytes. International Journal of Cancer. 22: 251-7. PMID 212371 DOI: 10.1002/Ijc.2910220306  0.381
1978 Pearson GR, Johansson B, Klein G. Antibody-dependent cellular cytotoxicity against Epstein-Barr virus-associated antigens in African patients with nasopharyngeal carcinoma. International Journal of Cancer. 22: 120-5. PMID 212366 DOI: 10.1002/Ijc.2910220203  0.316
1978 McConnell I, Klein G, Lint TF, Lachmann PJ. Activation of the alternative complement pathway by human B cell lymphoma lines is associated with Epstein-Barr virus transformation of the cells. European Journal of Immunology. 8: 453-8. PMID 211040 DOI: 10.1002/eji.1830080702  0.319
1978 Steinitz M, Koskimies S, Klein G, Mäkelä O. Establishment of specific antibody producing human lines by antigen preselection and EBV-transformation. Current Topics in Microbiology and Immunology. 81: 156-63. PMID 211003 DOI: 10.1007/978-3-642-67448-8_25  0.457
1978 Klein G, Falk L, Falk K. Antigen-inducing ability of herpesvirus papio in human and baboon lymphoma lines, compared to epstein-barr virus Intervirology. 10: 153-164. PMID 210135 DOI: 10.1159/000148980  0.444
1978 Wiener F, Ohno S, Spira J, Haran-Ghera N, Klein G. Chromosome Changes (Trisomies #15 and 17) Associated With Tumor Progression in Leukemias Induced by Radiation Leukemia Virus Journal of the National Cancer Institute. 61: 227-237. PMID 209203 DOI: 10.1093/Jnci/61.1.227  0.383
1978 Shapiro IM, Andersson-Anvret M, Klein G. Polyploidization of epstein-barr virus (Ebv)-carrying lymphoma lines decreases the inducibility of ebv-determined early antigen following p3hr-1 virus superinfection or iododeoxyuridine treatment Intervirology. 10: 94-101. PMID 209000 DOI: 10.1159/000148973  0.443
1978 Steinitz M, Bakács T, Yefenof E, Klein G. Inhibition of DNA metabolism in human B lymphocytes by a substrain of Epstein-Barr virus (P3HR-1): a method for virus quantitation. Intervirology. 10: 125-31. PMID 208998 DOI: 10.1159/000148977  0.374
1978 Kiessling R, Haller O, Fenyö EM, Steinitz M, Klein G. Mouse natural killer (NK) cell activity against human cell lines is not influenced by superinfection of the target cell with xenotropic murine C-type virus. International Journal of Cancer. 21: 460-5. PMID 208982 DOI: 10.1002/Ijc.2910210410  0.409
1978 Viallat J, Svedmyr E, Steinitz M, Klein G. Stimulation of peripheral human lymphocytes by autologous EBV genome-carrying lymphoblastoid cell lines. Cellular Immunology. 38: 68-75. PMID 208783 DOI: 10.1016/0008-8749(78)90032-1  0.396
1978 Moar MH, Klein G. Detection of Epstein-Barr virus (EBV) DNA sequences using in situ hybridization. Biochimica Et Biophysica Acta. 519: 49-64. PMID 208612 DOI: 10.1016/0005-2787(78)90061-8  0.343
1978 Klein G, Yefenof E, Falk K, Westman A. Relationship between Epstein-Barr virus (EBV)-production and the loss of the EBV receptor/complement receptor complex in a series of sublines derived from the same original Burkitt's lymphoma. International Journal of Cancer. 21: 552-60. PMID 207646 DOI: 10.1002/Ijc.2910210504  0.337
1978 Luka J, Klein G, Henle W, Henle G. Detection of the EBV-determined nuclear antigen (EBNA) in Burkitt's lymphoma and nasopharyngeal carcinoma biopsies by the acid fixed nuclear binding (AFNB) technique. Cancer Letters. 4: 199-205. PMID 206349 DOI: 10.1016/S0304-3835(78)94457-9  0.394
1978 Koliais S, Bjursell G, Adams A, Lindahl T, Klein G. State of Epstein-Barr virus DNA in an American Burkitt's lymphoma line. Journal of the National Cancer Institute. 60: 991-4. PMID 205666 DOI: 10.1093/Jnci/60.5.991  0.415
1978 Moar MH, Siegert W, Klein G. Autoradiographic detection of Epstein-Barr virus (EBV)-associated early antigen in a variety of EBV DNA-containing lymphoblastoid cell lines previously designated as nonproducers. Intervirology. 9: 333-43. PMID 204604 DOI: 10.1159/000148955  0.45
1978 Moar MH, Siegert W, Klein G. Autoradiographic detection of the Epstein-Barr virus (EBV)-associated early antigen (EA) in lymphoblastoid cell lines. Haematology and Blood Transfusion. 20: 283-7. PMID 204549 DOI: 10.1007/978-3-642-66639-1_35  0.458
1978 Gunvén P, Klein G, Ziegler JL, Magrath IT, Olweny CL, Henle W, Henle G, Svedmyr A, Demissie A. Epstein-Barr virus-associated and other antiviral antibodies during intense BCG administration to patients with Burkitt's lymphoma in remission. Journal of the National Cancer Institute. 60: 31-7. PMID 203706 DOI: 10.1093/Jnci/60.1.31  0.364
1978 Kuzumaki N, Fenyö EM, Giovanella BC, Klein G. Increased immunogenicity of low-antigenic rat tumors after superinfection with endogenous murine C-type virus in nude mice. International Journal of Cancer. 21: 62-66. PMID 203542 DOI: 10.1002/Ijc.2910210111  0.344
1978 Goldblum N, Ben-Bassat H, Mitrani S, Andersson-Anvret M, Goldblum T, Aghai E, Ramot B, Klein G. A case of an Epstein--Barr virus (EBV) genome-carrying lymphoma in an Israeli Arab child. European Journal of Cancer. 13: 693-8. PMID 202470 DOI: 10.1016/0014-2964(77)90055-X  0.417
1978 Einhorn L, Steinitz M, Yefenof E, Ernberg I, Bakacs T, Klein G. Epstein-Barr virus (EBV) receptors, complement receptors, and EBV infectibility of different lymphocyte fractions of human peripheral blood. II. Epstein-Barr virus studies. Cellular Immunology. 35: 43-58. PMID 202404 DOI: 10.1016/0008-8749(78)90125-9  0.402
1978 Spira J, Povey S, Wiener F, Klein G, Andersson-Anvret M. Chromosome banding, isoenzyme studies and determination of Epstein-Barr virus DNA content on human Burkitt lymphoma/mouse hybrids. International Journal of Cancer. 20: 849-53. PMID 201572 DOI: 10.1002/Ijc.2910200605  0.372
1978 Steinitz M, Klein G. Further studies on the differences in serum dependence in EBV negative lymphoma lines and their in vitro EBV converted, virus-genome carrying sublines. European Journal of Cancer. 13: 1269-75. PMID 201467 DOI: 10.1016/0014-2964(77)90035-4  0.36
1978 Beutler B, Nagai Y, Ohno S, Klein G, Shapiro IM. The HLA-dependent expression of testis- organizing H-Y antigen by human male cells. Cell. 13: 509-13. PMID 77737 DOI: 10.1016/0092-8674(78)90324-0  0.331
1978 Vestergaard BF, Hesse J, Norrild B, Klein G. Production of rabbit antibodies against the viral capsid antigen (VCA) of the Epstein-Barr virus (EBV). International Journal of Cancer. 21: 323-8. PMID 75856 DOI: 10.1002/Ijc.2910210312  0.322
1978 Dölken G, Klein G. Radioimmunoassay for Epstein--Barr virus (EBV)-associated nuclear antigen (EBNA). Binding of iodinated antibodies to antigen immobilized in polyacrylamide gel. European Journal of Cancer. 13: 1277-86. PMID 73461 DOI: 10.1016/0014-2964(77)90036-6  0.427
1978 Luka J, Lindahl T, Klein G. Purification of the Epstein-Barr virus-determined nuclear antigen from Epstein-Barr virus-transformed human lymphoid cell lines. Journal of Virology. 27: 604-611. DOI: 10.1128/Jvi.27.3.604-611.1978  0.374
1978 Becker S, Kiessling R, Lee N, Klein G. Modulation of Sensitivity to Natural Killer Cell Lysis After In Vitro Explantation of a Mouse Lymphoma Journal of the National Cancer Institute. 61: 1495-1498. DOI: 10.1093/Jnci/61.6.1495  0.399
1978 Klein GO, Klein G, Kiessling R, Karre K. H-2-associated control of natural cytotoxicity and hybrid resistance against RBL-5 Immunogenetics. 6: 561-569. DOI: 10.1007/Bf01563946  0.388
1977 Galili N, Naor D, Asjö B, Klein G. Induction of immune responsiveness in a genetically low-responsive tumor-host combination by chemical modification of the immunogen. European Journal of Immunology. 6: 473-6. PMID 991914 DOI: 10.1002/Eji.1830060705  0.367
1977 Klein G. Tumor associated antigens in H 2 hemizygous isoantigenic variants of a somatic cell hybrid derived from the fusion of a 3 methylcholanthrene induced sarcoma and a mammary carcinoma Journal of the National Cancer Institute. 58: 383-386. PMID 833884 DOI: 10.1093/Jnci/58.2.383  0.341
1977 Rosén A, Clements G, Klein G, Zeuthen J. Double immunoglobulin production in cloned somatic cell hybrids between two human lymphoid cell lines. Cell. 11: 139-47. PMID 406048 DOI: 10.1016/0092-8674(77)90324-5  0.359
1977 Siegert W, Moar MH, Bell C, Klein G. Demonstration of complement receptors on lymphoblastoid cells by radiolabeled antibodies and in situ autoradiography. Cellular Immunology. 31: 234-41. PMID 326422 DOI: 10.1016/0008-8749(77)90025-9  0.347
1977 Klein G, Terasaki P, Billing R, Honig R, Jondal M, Rosén A, Zeuthen J, Clements G. Somatic cell hybrids between human lymphoma lines. III. Surface markers. International Journal of Cancer. 19: 66-76. PMID 319066 DOI: 10.1002/Ijc.2910190110  0.359
1977 Andersson-Anvret M, Forsby N, Klein G, Henle W. Relationship between the Epstein-Barr virus and undifferentiated nasopharyngeal carcinoma: correlated nucleic acid hybridization and histopathological examination. International Journal of Cancer. Journal International Du Cancer. 20: 486-94. PMID 199543 DOI: 10.1002/Ijc.2910200403  0.364
1977 Steinitz M, Klein G, Koskimies S, Makel O. EB virus-induced B lymphocyte cell lines producing specific antibody. Nature. 269: 420-422. PMID 198669 DOI: 10.1038/269420A0  0.429
1977 Yefenof E, Klein G. Membrane receptor stripping confirms the association between EBV receptors and complement receptors on the surface of human B lymphoma lines. International Journal of Cancer. 20: 347-52. PMID 198382 DOI: 10.1002/Ijc.2910200305  0.307
1977 Yefenof E, Klein G, Ben-Bassat H, Lundin L. Differences in the ConA-induced redistribution and agglutination patterns of EBV genome-free and EBV-carrying human lymphoma lines. Experimental Cell Research. 108: 185-90. PMID 196869 DOI: 10.1016/S0014-4827(77)80024-4  0.362
1977 Klein G, Clements G, Zeuthen J, Westman A. Spontaneous and induced patterns of the Epstein-Barr virus (EBV) cycle in a new set of somatic cell hybrids. Cancer Letters. 3: 91-8. PMID 196751 DOI: 10.1016/S0304-3835(77)94516-5  0.442
1977 Moar MH, Siegert W, Klein G. Detection localization of Epstein-Barr virus-associated early antigens in single cells by autoradiography using 125I-labeled antibodies. (With 1 color plate). Intervirology. 8: 226-239. PMID 194866 DOI: 10.1159/000148898  0.397
1977 Klein G, Klein E. Immune surveillance against virus-induced tumors and nonrejectability of spontaneous tumors: contrasting consequences of host versus tumor evolution. Proceedings of the National Academy of Sciences of the United States of America. 74: 2121-5. PMID 194247 DOI: 10.1073/Pnas.74.5.2121  0.355
1977 Rosén A, Gergely P, Jondal M, Klein G, Britton S. Polyclonal Ig production after Epstein-Barr virus infection of human lymphocytes in vitro Nature. 267: 52-54. PMID 193041 DOI: 10.1038/267052A0  0.413
1977 Dölken G, Klein G. A solid-phase radioimmunoassay for Epstein-Barr virus-associated membrane antigen prepared from B95-8 cell culture supernatants. Journal of the National Cancer Institute. 58: 1239-45. PMID 192896 DOI: 10.1093/Jnci/58.5.1239  0.372
1977 Olweny CL, Atine I, Kaddu-Mukasa A, Owor R, Andersson-Anvret M, Klein G, Henle W, de-Thé G. Epstein-Barr virus genome studies in Burkitt's and non-Burkitt's lymphomas in Uganda. Journal of the National Cancer Institute. 58: 1191-6. PMID 192894 DOI: 10.1093/Jnci/58.5.1191  0.404
1977 Ernberg I, Andersson-Anvret M, Klein G, Lundin L, Killanger D. Relationship between amount of Epstein-Barr virus-determined nuclear antigen per cell and number of EBV-DNA copies per cell. Nature. 266: 269-71. PMID 191759 DOI: 10.1038/266269A0  0.366
1977 Dalianis T, Klein G, Andersson B. Column separation of viral capsid antigen (VCA)-positive cells from VCA-negative cells in an Epstein-Barr virus (EBV)-producing lymphoid line,. International Journal of Cancer. 19: 460-7. PMID 191413 DOI: 10.1002/Ijc.2910190405  0.433
Show low-probability matches.